DE122007000007I1
(de)
|
1986-04-09 |
2007-05-16 |
Genzyme Corp |
Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
|
US5322775A
(en)
*
|
1986-06-30 |
1994-06-21 |
Pharmaceutical Proteins Ltd. |
Peptide production
|
EP0832981A1
(de)
*
|
1987-02-17 |
1998-04-01 |
Pharming B.V. |
DNA-Sequenzen die Proteine zwecks effizienter Abscheidung zur Milchdrüse leiten
|
US6054566A
(en)
*
|
1988-02-26 |
2000-04-25 |
Biosource Technologies, Inc. |
Recombinant animal viral nucleic acids
|
US6284492B1
(en)
*
|
1988-02-26 |
2001-09-04 |
Large Scale Biology Corporation |
Recombinant animal viral nucleic acids
|
US5316931A
(en)
*
|
1988-02-26 |
1994-05-31 |
Biosource Genetics Corp. |
Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
|
US20030150019A1
(en)
*
|
1988-02-26 |
2003-08-07 |
Large Scale Biology Corporation |
Monopartite RNA virus transformation vectors
|
US6241982B1
(en)
*
|
1988-03-21 |
2001-06-05 |
Chiron Corporation |
Method for treating brain cancer with a conditionally lethal gene
|
US6020015A
(en)
*
|
1988-09-22 |
2000-02-01 |
Gaull; Gerald E. |
Infant formula compositions and nutrition containing genetically engineered human milk proteins
|
GB8823869D0
(en)
*
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
GB8826446D0
(en)
*
|
1988-11-11 |
1988-12-14 |
Agricultural & Food Res |
Peptide production
|
US5650503A
(en)
*
|
1988-11-11 |
1997-07-22 |
Ppl Therapeutics (Scotland) Limited |
Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals
|
EP0370813A3
(de)
*
|
1988-11-25 |
1991-06-19 |
Exemplar Corporation |
Rascher Überprüfungstest der Mutagenesis und Tetratogenesis
|
US5215904A
(en)
*
|
1989-01-27 |
1993-06-01 |
Wisconsin Alumni Research Foundation |
Method for producing a recombinant mammal in vivo
|
JPH02261386A
(ja)
*
|
1989-03-31 |
1990-10-24 |
Kyowa Hakko Kogyo Co Ltd |
組換えベクター
|
CA2065866A1
(en)
*
|
1989-09-11 |
1991-03-12 |
Vermuri B. Reddy |
Production of growth hormone in transgenic animal milk
|
EP0897987B1
(de)
*
|
1989-10-24 |
2001-02-28 |
Chiron Corporation |
Sekretion vom mit Gamma-Interferon Signalpeptid gebundenen humänen Protein
|
US5633076A
(en)
*
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
WO1993025567A1
(en)
*
|
1992-06-15 |
1993-12-23 |
Gene Pharming Europe B.V. |
Production of recombinant polypeptides by bovine species and transgenic methods
|
ATE140027T1
(de)
*
|
1989-12-01 |
1996-07-15 |
Pharming Bv |
Herstellung rekombinanter polypeptide durch rinder und transgene methoden
|
WO1991013151A1
(en)
*
|
1990-02-22 |
1991-09-05 |
Biogen, Inc. |
Improved expression of polypeptides
|
US5674898A
(en)
*
|
1990-03-05 |
1997-10-07 |
Genzyme Corporation |
Methods and therapeutic compositions for treating cystic fibrosis
|
JPH04365487A
(ja)
*
|
1990-04-11 |
1992-12-17 |
Consortium Elektrochem Ind Gmbh |
組換dna−構造体、組換ベクター、トランスゲン動物の乳からの蛋白質の取得法、トランスゲン動物の製法及びトランスゲン動物の乳
|
WO1992006104A1
(en)
*
|
1990-09-28 |
1992-04-16 |
The Dana-Farber Cancer Institute |
Adipocyte-specific dna sequences and use for the production of transgenic animals exhibiting altered fat metabolism
|
US6262336B1
(en)
|
1991-01-11 |
2001-07-17 |
American Red Cross |
Expression of a heterologous protein C in mammary tissue of transgenic animals using a long whey acidic protein promoter
|
US5965789A
(en)
*
|
1991-01-11 |
1999-10-12 |
American Red Cross |
Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals
|
US6984772B1
(en)
*
|
1994-02-18 |
2006-01-10 |
Virginia Tech Intellectual Properties, Inc. |
Transgenic non-human mammals producing fibrinogen in their milk
|
US5831141A
(en)
*
|
1991-01-11 |
1998-11-03 |
United States Of America As Represented By The Department Of Health And Human Services |
Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter
|
JPH06507307A
(ja)
*
|
1991-01-11 |
1994-08-25 |
アメリカン・レツド・クロス |
トランスジェニック動物の乳腺組織における活性ヒトプロテインcの発現
|
US6268545B1
(en)
|
1991-06-12 |
2001-07-31 |
Institut National De La Recherche Agronomique |
Transgenic non-human mammal comprising a rabbit WAP promoter, uses thereof, and a DNA construct comprising the rabbit WAP promoter
|
US5965788A
(en)
*
|
1992-06-12 |
1999-10-12 |
Institut National De La Recherche Agronomique |
Transgenic non-human mammal comprising a rabbit WAP promoter
|
AU669484B2
(en)
*
|
1991-07-31 |
1996-06-13 |
Peri Development Applications (1985) Ltd |
Transgenic protein production
|
GB9119338D0
(en)
*
|
1991-09-10 |
1991-10-23 |
Inst Of Animal Physiology And |
Control of gene expression
|
US6448469B1
(en)
*
|
1991-10-02 |
2002-09-10 |
Genzyme Corporation |
Production of membrane proteins in the milk of transgenic nonhuman mammals
|
US5298422A
(en)
*
|
1991-11-06 |
1994-03-29 |
Baylor College Of Medicine |
Myogenic vector systems
|
DK8892D0
(da)
*
|
1992-01-23 |
1992-01-23 |
Symbicom Ab |
Humant proteingen
|
HRP930935A2
(en)
*
|
1992-06-11 |
1994-12-31 |
Astra Ab |
New dna sequences
|
PT672136E
(pt)
*
|
1992-07-08 |
2000-08-31 |
Innogenetics Nv |
Polipeptidos derivados da endonexina 2 tendo actividade receptora do virus da hepatite b e sua utilizacao em diagnostico e composicoes farmaceuticas
|
DE4233152A1
(de)
|
1992-10-02 |
1994-04-07 |
Behringwerke Ag |
Antikörper-Enzym-Konjugate zur Prodrug-Aktivierung
|
US5667839A
(en)
*
|
1993-01-28 |
1997-09-16 |
Collagen Corporation |
Human recombinant collagen in the milk of transgenic animals
|
ATE193301T1
(de)
*
|
1993-03-09 |
2000-06-15 |
Genzyme Corp |
Verfahren zur isolierung von proteinen aus milch
|
DK75393D0
(da)
*
|
1993-06-24 |
1993-06-24 |
Symbicom Ab |
Production of protein
|
WO1995003402A1
(en)
*
|
1993-07-22 |
1995-02-02 |
Merck & Co., Inc. |
EXPRESSION OF HUMAN INTERLEUKIN-1β IN A TRANSGENIC ANIMAL
|
JPH09500533A
(ja)
*
|
1993-07-22 |
1997-01-21 |
メルク エンド カンパニー インコーポレーテッド |
認識障害に関するトランスジェニック動物モデル
|
US5856178A
(en)
*
|
1993-08-30 |
1999-01-05 |
Utah State University |
DNA cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same
|
RU2025487C1
(ru)
*
|
1993-10-18 |
1994-12-30 |
Товарищество с ограниченной ответственностью "БиоПрогресс" |
Способ направленной генетической трансформации молочной железы животного и устройство для введения генетического материала в молочный проток молочной железы животного
|
US5750367A
(en)
*
|
1993-11-08 |
1998-05-12 |
Baylor College Of Medicine |
Human and mouse very low density lipoprotein receptors and methods for use of such receptors
|
US5827690A
(en)
*
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
AU5657800A
(en)
*
|
1993-12-20 |
2000-11-23 |
Gtc Biotherapeutics, Inc. |
Transgenic production of antibodies in milk
|
US5639940A
(en)
|
1994-03-03 |
1997-06-17 |
Pharmaceutical Proteins Ltd. |
Production of fibrinogen in transgenic animals
|
US5888814A
(en)
*
|
1994-06-06 |
1999-03-30 |
Chiron Corporation |
Recombinant host cells encoding TNF proteins
|
US6713662B1
(en)
*
|
1994-07-27 |
2004-03-30 |
Pharming Intellectual Property B.V. |
Production of collagen in the milk of transgenic mammals
|
US5959171A
(en)
*
|
1994-08-17 |
1999-09-28 |
Pharming B.V. |
Method for the production of biologically active polypeptides in a mammal's
|
US6518482B2
(en)
|
1994-09-13 |
2003-02-11 |
American National Red Cross |
Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor
|
US5880327A
(en)
|
1994-09-21 |
1999-03-09 |
American National Red Cross |
Transgenic mammals expressing human coagulation factor VIII
|
WO1996012792A1
(en)
*
|
1994-10-20 |
1996-05-02 |
Merck & Co., Inc. |
INTERLEUKIN-1β DEFICIENT TRANSGENIC ANIMALS
|
US5780009A
(en)
*
|
1995-01-20 |
1998-07-14 |
Nexia Biotechnologies, Inc. |
Direct gene transfer into the ruminant mammary gland
|
US5843705A
(en)
*
|
1995-02-21 |
1998-12-01 |
Genzyme Transgenic Corporation |
Transgenically produced antithrombin III
|
JPH11511979A
(ja)
*
|
1995-09-06 |
1999-10-19 |
ババリアン・ノルディック・リサーチ・インスティテュート・アクティーゼルスカブ |
ヒト乳癌細胞を含むヒト乳腺細胞を標的として、連結された異種性遺伝子を発現させるためのwapまたはmmtv制御配列の使用
|
US5907080A
(en)
*
|
1995-11-30 |
1999-05-25 |
Nexia Biotechnologies, Inc. |
Method for development of transgenic dwarf goats
|
US6613544B1
(en)
*
|
1995-12-22 |
2003-09-02 |
Amgen Inc. |
Osteoprotegerin
|
US7632922B1
(en)
*
|
1995-12-22 |
2009-12-15 |
Amgen, Inc. |
Osteoprotegerin
|
SE9601091L
(sv)
*
|
1996-03-21 |
1997-09-22 |
Joyce Carlson |
Användning av en proteinsubstans för bindning av steroid-liknande molekyler
|
US6025155A
(en)
*
|
1996-04-10 |
2000-02-15 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US6077697A
(en)
*
|
1996-04-10 |
2000-06-20 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US20020160970A1
(en)
*
|
1996-04-10 |
2002-10-31 |
Gyula Hadlaczky |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US20030033617A1
(en)
*
|
1996-04-10 |
2003-02-13 |
Gyula Hadlaczky |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
WO1998003206A1
(en)
*
|
1996-07-24 |
1998-01-29 |
University Of Maryland |
The butyrophilin gene promoter and uses thereof
|
JP4509224B2
(ja)
|
1996-09-06 |
2010-07-21 |
ポール・コーポレーション |
剪断分離方法及びシステム
|
US6344596B1
(en)
*
|
1997-02-14 |
2002-02-05 |
American Red Cross |
Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals
|
US6528699B1
(en)
*
|
1997-02-25 |
2003-03-04 |
Genzyme Transgenics Corporation |
Transgenically produced non-secreted proteins
|
EP1522591A3
(de)
*
|
1997-02-25 |
2005-08-17 |
GTC Biotherapeutics, Inc. |
Transgen produzierte nicht-sekretierte Proteine
|
DK0975755T3
(da)
|
1997-04-16 |
2007-06-11 |
Millennium Pharm Inc |
CRSP-protein (cysteinrige udskilte proteiner), nukleinsyremolekyler der koder herfor samt anvendelser deraf
|
US6210736B1
(en)
|
1997-06-17 |
2001-04-03 |
Genzyme Transgenics Corporation |
Transgenically produced prolactin
|
US6087166A
(en)
|
1997-07-03 |
2000-07-11 |
Basf Aktiengesellschaft |
Transcriptional activators with graded transactivation potential
|
US6323008B1
(en)
*
|
1997-08-14 |
2001-11-27 |
Neose Technologies, Inc. |
Methods for producing sialyloligosaccharides in a dairy source
|
WO1999009816A1
(de)
*
|
1997-08-22 |
1999-03-04 |
Roche Diagnostics Gmbh |
Verfahren zur gewinnung von insulin precursorproteinen
|
EP1025244A2
(de)
*
|
1997-10-20 |
2000-08-09 |
Genzyme Transgenics Corporation |
Neue modifizierte msp-1 nukleinsäuresequenzen und verfahren zur erhöhung der mrna-niveau und der proteinexpression in zellsystemen
|
US7157615B2
(en)
|
1998-03-17 |
2007-01-02 |
Nexia Biotechnologies, Inc. |
Production of biofilaments in transgenic animals
|
US6746852B1
(en)
|
1998-05-08 |
2004-06-08 |
Osi Pharmaceuticals, Inc. |
AGS proteins and nucleic acid molecules and uses thereof
|
US6733991B1
(en)
*
|
1998-05-08 |
2004-05-11 |
Osi Pharmaceuticals, Inc. |
AGS proteins and nucleic acid molecules and uses therefor
|
CN1107445C
(zh)
*
|
1998-05-08 |
2003-05-07 |
上海市儿童医院上海医学遗传研究所 |
一种转基因羊的制备方法
|
US7700353B2
(en)
*
|
1998-07-22 |
2010-04-20 |
E-P Therapeutics, Inc. |
Compositions and methods for inducing apoptosis in tumor cells
|
US20060205034A1
(en)
*
|
1998-10-30 |
2006-09-14 |
Millennium Pharmaceuticals, Inc. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
|
US20030027998A1
(en)
*
|
1998-10-30 |
2003-02-06 |
Holtzman Douglas A. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
|
CA2354638C
(en)
|
1999-01-06 |
2013-03-19 |
Atlantic Biopharmaceuticals, Inc. |
Expression of secreted human alpha-fetoprotein in transgenic animals
|
US7208576B2
(en)
|
1999-01-06 |
2007-04-24 |
Merrimack Pharmaceuticals, Inc. |
Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
|
WO2000050057A1
(en)
*
|
1999-02-22 |
2000-08-31 |
Bernstein Eric F |
Compositions and methods for prevention of photoaging
|
EP2301947A3
(de)
|
1999-02-26 |
2011-11-23 |
Millennium Pharmaceuticals, Inc. |
Sekretierte Proteine und Verwendungen dafür
|
AR022952A1
(es)
|
1999-03-19 |
2002-09-04 |
Smithkline Beecham Corp |
ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
|
WO2000061725A1
(en)
*
|
1999-04-14 |
2000-10-19 |
Genzyme Transgenics Corp. |
Method of purifying heterologous proteins
|
US20040229779A1
(en)
*
|
1999-05-14 |
2004-11-18 |
Ramesh Kekuda |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US6974684B2
(en)
*
|
2001-08-08 |
2005-12-13 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20040023874A1
(en)
*
|
2002-03-15 |
2004-02-05 |
Burgess Catherine E. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US6774120B1
(en)
*
|
1999-06-01 |
2004-08-10 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
US20040067490A1
(en)
*
|
2001-09-07 |
2004-04-08 |
Mei Zhong |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US6183803B1
(en)
|
1999-06-11 |
2001-02-06 |
Biosante Pharmaceuticals, Inc. |
Method for processing milk
|
EP1263963A2
(de)
|
1999-06-25 |
2002-12-11 |
Basf Aktiengesellschaft |
Gene von corynebacterium glutamicum kodierend für kohlenstoffstoffwechsel- und energieproduktionproteine
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
TR200403465T2
(tr)
|
1999-07-01 |
2005-03-21 |
Basf Aktiengesellschaft |
Corynebacterium glutamicum gen kodlayıcı fosfonolpiruvat:seker fosfotransferaz sistem proteini
|
DE1246922T1
(de)
|
1999-07-01 |
2003-03-20 |
Basf Ag |
Für proteine des phosphoenolpyruvat:zucker phosphotransferase systems kodierende gene aus corynebacterium glutamicum
|
EP1204674A4
(de)
*
|
1999-07-27 |
2005-06-01 |
Abgenix Inc |
Methoden und verbindungen zur verhinderung von polypeptid-ansammlungen im zusammenhang mit neurologischen störungen
|
WO2001011952A1
(en)
*
|
1999-08-19 |
2001-02-22 |
Us Transgenics, Inc. |
Transgenic prothrombin and related thrombin precursors and transgenics, methods, compositions, uses and the like relating thereto
|
CA2383456C
(en)
|
1999-08-23 |
2016-06-07 |
Clive Wood |
Pd-1, a receptor for b7-4, and uses therefor
|
AT411997B
(de)
|
1999-09-14 |
2004-08-26 |
Baxter Ag |
Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate
|
US6855806B1
(en)
*
|
1999-10-15 |
2005-02-15 |
Curagen Corporation |
Thymosin beta 10-like proteins and nucleic acids encoding same
|
WO2001029071A2
(en)
*
|
1999-10-19 |
2001-04-26 |
Curagen Corporation |
Genes associated with obesity and methods for using the same
|
US7074983B2
(en)
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
US7820878B2
(en)
*
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
WO2001035735A1
(en)
*
|
1999-11-19 |
2001-05-25 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US7414170B2
(en)
*
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
US20030157592A1
(en)
*
|
1999-12-16 |
2003-08-21 |
Jens Lerchl |
Moss genes from physcomitrella patens encoding proteins involved in the synthesis of tocopherols and carotenoids
|
JP2003518942A
(ja)
|
1999-12-30 |
2003-06-17 |
プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ |
肝細胞成長、形質細胞分化、又はt細胞サブセットの活性を、xbp−1活性の変調により変調することに関する方法及び組成物
|
KR20020073580A
(ko)
|
2000-02-09 |
2002-09-27 |
바스프 악티엔게젤샤프트 |
신규 연장효소 유전자 및 다가불포화 지방산의 제조 방법
|
WO2001064882A2
(en)
|
2000-02-29 |
2001-09-07 |
Millennium Pharmaceuticals, Inc. |
1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor
|
WO2001066747A2
(en)
*
|
2000-03-03 |
2001-09-13 |
Curagen Corporation |
Proteins named fctrx and nucleic acids encoding same
|
ATE374597T1
(de)
*
|
2000-03-24 |
2007-10-15 |
Biosphere Medical Inc |
Mikrokugeln zur aktiven embolisierung
|
US20030212022A1
(en)
*
|
2001-03-23 |
2003-11-13 |
Jean-Marie Vogel |
Compositions and methods for gene therapy
|
DE10016877A1
(de)
*
|
2000-04-05 |
2001-10-18 |
Scintec Diagnostics Gmbh Zug |
(Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung
|
AU2001255250A1
(en)
|
2000-04-07 |
2001-10-23 |
Basf Plant Science Gmbh |
Cell cycle stress-related proteins and methods of use in plants
|
US20030219786A1
(en)
*
|
2000-08-11 |
2003-11-27 |
Applied Research Systems Ars Holding N.V. |
Novel glycoproteins and methods of use thereof
|
US20040005554A1
(en)
*
|
2000-05-08 |
2004-01-08 |
Tayar Nabil El |
Novel glycoproteins and methods of use thereof
|
EP1714661A3
(de)
|
2000-05-19 |
2012-03-14 |
The Center for Blood Research, INC. |
Verfahren zur Diagnose und Behandlung von hämostatischen Störungen durch Modulation der P-Selectin Aktivität
|
US20040034193A1
(en)
*
|
2001-06-13 |
2004-02-19 |
Samy Ashkar |
Biosynthetic oncolytic molecules and uses therefor
|
US20050048614A1
(en)
*
|
2000-06-13 |
2005-03-03 |
Children's Medical Center Corporation |
Biosynthetic oncolytic molecules and uses therefor
|
CA2413857C
(en)
|
2000-06-28 |
2010-04-27 |
Genetics Institute, Llc. |
Pd-l2 molecules: pd-1 ligands and uses therefor
|
WO2002006330A2
(en)
|
2000-07-18 |
2002-01-24 |
Millennium Pharmaceuticals, Inc. |
13237,18480,2245 or 16228 human protein kinase molecules and uses therefor
|
US6924412B1
(en)
*
|
2000-07-21 |
2005-08-02 |
Arriwan Holding B.V. |
Means and methods for raising antibody concentration in compartments of the body of a non-human animal
|
US20040023259A1
(en)
*
|
2000-07-26 |
2004-02-05 |
Luca Rastelli |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
WO2002014473A2
(en)
*
|
2000-08-15 |
2002-02-21 |
Board Of Trustees Of The University Of Illinois |
Animals expressing exogenous igf-i in their milk
|
WO2002018583A2
(en)
|
2000-09-01 |
2002-03-07 |
The Center For Blood Research, Inc. |
Modified polypeptides stabilized in a desired conformation and methods for producing same
|
JP4361728B2
(ja)
|
2000-09-13 |
2009-11-11 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
ヒト凝固因子vii変異型
|
US20030176344A1
(en)
*
|
2000-09-14 |
2003-09-18 |
Decode Genetics Ehf. |
Human osteoporosis gene
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
ATE510908T1
(de)
*
|
2000-09-28 |
2011-06-15 |
Bioriginal Food & Science Corp |
Fad5-2, mitglied der desaturase-familie und verwendungen davon
|
DK2174954T3
(en)
|
2000-10-18 |
2016-07-04 |
Robert Sackstein |
HEMATOPOIETIC CELL E-selectin / L-SELEKTINLIGAND polypeptides and methods of use thereof
|
US6821731B2
(en)
|
2000-11-28 |
2004-11-23 |
Wyeth |
Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis of prostate cancer
|
EP1343912A2
(de)
|
2000-11-28 |
2003-09-17 |
Wyeth |
Expressionsanalyse von kiaa nukleinsäuren und polypeptiden, geeignet zur diagnose und zur behandlung von prostatakrebs
|
AU2002226079A1
(en)
|
2000-12-08 |
2002-06-18 |
Curagen Corporation |
Method of detecting and treating tuberous sclerosis complex associated disorders
|
US7247704B2
(en)
*
|
2000-12-18 |
2007-07-24 |
Arriva Pharmaceuticals, Inc. |
Multifunctional protease inhibitors and their use in treatment of disease
|
US20020142397A1
(en)
*
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
US7491534B2
(en)
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
US7981420B2
(en)
|
2000-12-22 |
2011-07-19 |
Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. |
Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)
|
EP1356035B1
(de)
|
2000-12-22 |
2011-03-16 |
Kyowa Hakko Kirin Co., Ltd. |
Verfahren zur klonierung von nichtmenschliche säugern unter verwendung von reprogrammiertem donorchromatin oder donorzellen
|
US6964849B2
(en)
|
2001-01-11 |
2005-11-15 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
US20040043928A1
(en)
*
|
2001-08-02 |
2004-03-04 |
Ramesh Kekuda |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
GB0103174D0
(en)
*
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Plc |
Novel method of treatment
|
US20040133930A1
(en)
*
|
2002-03-11 |
2004-07-08 |
Cooper Julian D. |
Production of high levels of transgenic factor ix without gene rescue, and its therapeutic uses
|
US8231878B2
(en)
*
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
CA2342376C
(en)
*
|
2001-03-20 |
2013-11-12 |
Marco Colonna |
A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US20090081199A1
(en)
*
|
2001-03-20 |
2009-03-26 |
Bioxell S.P.A. |
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
CA2441580A1
(en)
|
2001-03-22 |
2002-10-03 |
Novo Nordisk Health Care Ag |
Coagulation factor vii derivatives
|
US7795494B2
(en)
*
|
2001-03-22 |
2010-09-14 |
Abbott Laboratories |
Transgenic mice expressing antibodies specific for genes of interest and uses thereof
|
GB0107510D0
(en)
*
|
2001-03-26 |
2001-05-16 |
Univ Bristol |
New elongase gene and a process for the production of -9-polyunsaturated fatty acids
|
JP2004533226A
(ja)
|
2001-04-02 |
2004-11-04 |
ワイス |
B7−4に対するpd−1、aレセプター、およびその使用
|
MXPA03009415A
(es)
|
2001-04-16 |
2004-01-29 |
Wyeth Corp |
ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS.
|
US20070015144A9
(en)
*
|
2001-05-25 |
2007-01-18 |
Genset, S.A. |
Human cDNAs and proteins and uses thereof
|
CA2448253A1
(en)
*
|
2001-05-25 |
2002-11-28 |
Genset S.A. |
Human cdnas and proteins and uses thereof
|
JP2004537297A
(ja)
*
|
2001-06-07 |
2004-12-16 |
ワイス |
G−タンパク質結合レセプターおよびその使用
|
US20030087274A1
(en)
*
|
2001-07-05 |
2003-05-08 |
Anderson David W. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20030129613A1
(en)
*
|
2001-07-05 |
2003-07-10 |
Fernandes Elma R. |
Novel human proteins and polynucleotides encoding them
|
US20040029790A1
(en)
*
|
2001-07-05 |
2004-02-12 |
Meera Patturajan |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
US20040030096A1
(en)
*
|
2001-08-02 |
2004-02-12 |
Linda Gorman |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
US7220718B2
(en)
*
|
2001-08-03 |
2007-05-22 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Oral treatment of hemophilia
|
IL160229A0
(en)
|
2001-08-10 |
2004-07-25 |
Genset Sa |
Polynucleotides, polypeptides encoded thereby and their use
|
US7091402B2
(en)
|
2001-09-05 |
2006-08-15 |
Basf Plant Science Gmbh |
Protein phosphates stress-related polypeptides and methods of use in plants
|
US20070082337A1
(en)
*
|
2004-01-27 |
2007-04-12 |
Compugen Ltd. |
Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
|
US20040142325A1
(en)
*
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
AU2002336760A1
(en)
*
|
2001-09-26 |
2003-06-10 |
Mayo Foundation For Medical Education And Research |
Mutable vaccines
|
CZ2004427A3
(cs)
|
2001-09-27 |
2004-08-18 |
Novoánordiskáhealthácareáag |
Polypeptidy lidského koagulačního faktoru VII
|
US20030199442A1
(en)
*
|
2001-10-09 |
2003-10-23 |
Alsobrook John P. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20050124022A1
(en)
*
|
2001-10-30 |
2005-06-09 |
Maithreyan Srinivasan |
Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
|
US6956114B2
(en)
|
2001-10-30 |
2005-10-18 |
'454 Corporation |
Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
|
US6902921B2
(en)
|
2001-10-30 |
2005-06-07 |
454 Corporation |
Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
|
DE10154270A1
(de)
|
2001-11-05 |
2003-05-15 |
Basf Ag |
Gene die für Kohlenstoffmetabolismus- und Energieproduktion-Proteine codieren
|
DE10154180A1
(de)
|
2001-11-05 |
2003-05-15 |
Basf Ag |
gene die für genetische Stabilitäts-, genexpressions-und Faltungsproteine codieren
|
JP2005514921A
(ja)
|
2001-11-09 |
2005-05-26 |
ダナ−ファーバー キャンサー インスティチュート インク |
PGC−1β、新規PGC−1相同体およびその用途
|
ES2365912T3
(es)
|
2001-11-09 |
2011-10-13 |
Basf Plant Science Gmbh |
Polipéptidos del factor de transcripción relacionados con el estrés y métodos de uso en plantas.
|
DE10155505A1
(de)
|
2001-11-13 |
2003-05-22 |
Basf Ag |
Gene die für Glucose-6-Phosphat-Dehydrogenase Proteine codieren
|
KR20100120246A
(ko)
|
2001-11-14 |
2010-11-12 |
센토코 오르토 바이오테크 인코포레이티드 |
항 il-6 항체, 조성물, 방법 및 용도
|
WO2003052120A2
(en)
*
|
2001-12-14 |
2003-06-26 |
President And Fellows Of Harvard College |
Dual inhibition of sister chromatide separation at metaphase
|
EP1455815A4
(de)
|
2001-12-19 |
2006-11-02 |
Millennium Pharm Inc |
Mitglieder der familie der humanen diacylglycerol-acyltransferase 2 (dgat2) und ihre verwendung
|
AU2002353374A1
(en)
*
|
2001-12-21 |
2003-07-09 |
Nexia Biotechnologies, Inc. |
Production of butyrylcholinesterases in transgenic mammals
|
US20060253913A1
(en)
*
|
2001-12-21 |
2006-11-09 |
Yue-Jin Huang |
Production of hSA-linked butyrylcholinesterases in transgenic mammals
|
US20070016969A1
(en)
*
|
2002-01-18 |
2007-01-18 |
Animal Technology Institute Taiwan |
Expression vector for hirudin and transformed cells and transgenic animals containing said vector
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US20050215478A1
(en)
*
|
2002-02-07 |
2005-09-29 |
Ben-Sasson Shmuel A |
Amino acid sequences capable of facilitating penetration across a biological barrier
|
JP2005517024A
(ja)
*
|
2002-02-07 |
2005-06-09 |
イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム |
生物学的障壁を横切る透過を促進し得るアミノ酸配列
|
US20040117862A1
(en)
*
|
2002-03-11 |
2004-06-17 |
Cooper Julian D. |
Production of high levels of transgenic factor VII with engineered stability and its therapeutic uses
|
DK1997512T3
(da)
|
2002-04-09 |
2014-01-27 |
Biogen Idec Inc |
Fremgangsmåder til behandling af TWEAK-relaterede tilstande
|
DK1572950T3
(da)
|
2002-06-17 |
2013-02-04 |
Thrasos Inc |
Enkeltdomæne TDF-relaterede forbindelser og analoger deraf
|
WO2004002417A2
(en)
|
2002-06-28 |
2004-01-08 |
Centocor, Inc. |
Mammalian ch1 deleted mimetibodies, compositions, methods and uses
|
US7081341B2
(en)
|
2002-07-01 |
2006-07-25 |
Wayne State University |
Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance
|
US7250551B2
(en)
*
|
2002-07-24 |
2007-07-31 |
President And Fellows Of Harvard College |
Transgenic mice expressing inducible human p25
|
TWI323265B
(en)
*
|
2002-08-06 |
2010-04-11 |
Glaxo Group Ltd |
Antibodies
|
DE10238433A1
(de)
*
|
2002-08-16 |
2004-03-04 |
Justus-Liebig-Universität Giessen |
Verfahren zur Bestimmung des allelischen Zustandes des 5'-Ende des alpha-S1-Kaseingenes
|
EP2311978A1
(de)
|
2002-08-20 |
2011-04-20 |
Millennium Pharmaceuticals, Inc. |
Zusammensetzungen, Kits und Verfahren zur Identifizierung, Beurteilung, Vorbeugung und Therapie von Gebärmutterhalskrebs
|
AU2003290689A1
(en)
*
|
2002-11-08 |
2004-06-03 |
Kyowa Hakko Kirin Co., Ltd. |
Transgenic ungulates having reduced prion protein activity and uses thereof
|
US20060009378A1
(en)
|
2002-11-14 |
2006-01-12 |
Itshak Golan |
Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
US20070042978A1
(en)
*
|
2002-12-19 |
2007-02-22 |
Jean-Philippe Girard |
Nf-hev compositions and methods of use
|
EP1583713B1
(de)
*
|
2003-01-07 |
2009-03-25 |
Ramot at Tel Aviv University Ltd. |
Peptidenanostrukturen die fremdmaterial enthalten, und verfahren zur herstellung derselben
|
EP2319857A3
(de)
|
2003-03-04 |
2012-06-27 |
Yeda Research And Development Co., Ltd. |
Pon-Polypeptide, diese codierende Polynukleotide und Zusammensetzungen und verfahren unter Verwendung davon
|
NZ542549A
(en)
|
2003-03-04 |
2008-11-28 |
Aspenbio Pharma Inc |
Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using single-chain luteinizing hormone
|
AU2004222361A1
(en)
*
|
2003-03-04 |
2004-09-30 |
Janssen Pharmaceutica N.V. |
Relaxin3-GPCR135 complexes and their production and use
|
KR101204712B1
(ko)
|
2003-03-18 |
2012-11-27 |
노보 노르디스크 헬스 케어 악티엔게젤샤프트 |
Gla-잔기 함유 세린 프로테아제의 제조 방법
|
GB0306309D0
(en)
*
|
2003-03-19 |
2003-04-23 |
Glaxo Group Ltd |
Method of treatment
|
US7524938B2
(en)
|
2003-04-04 |
2009-04-28 |
Yeda Research And Development Co., Ltd. |
Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
|
AU2004227204B2
(en)
|
2003-04-08 |
2010-06-03 |
Yeda Research And Development Co. Ltd |
Stem cells having increased sensitivity to SDF-1 and methods of generating and using same
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
CA2530927A1
(en)
|
2003-06-30 |
2005-01-06 |
Tel Aviv University Future Technology Development L.P. |
Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
|
CA2531773A1
(en)
|
2003-07-21 |
2005-02-17 |
Transgene S.A. |
Novel multifunctional cytokines
|
AU2004263512A1
(en)
*
|
2003-08-07 |
2005-02-17 |
Janssen Pharmaceutica N.V. |
Complexes of GPCR142 and relaxin3 or INSL5, and their production and use
|
PL2520654T3
(pl)
|
2003-08-26 |
2017-08-31 |
The Regents Of The University Of Colorado, A Body Corporate |
Inhibitory aktywności proteazy serynowej i ich zastosowanie w sposobach i kompozycjach do leczenia zakażeń bakteryjnych
|
US20060258576A1
(en)
*
|
2003-09-05 |
2006-11-16 |
Licentia, Ltd |
Gdnf-related neuropeptides
|
CN1871252A
(zh)
*
|
2003-09-05 |
2006-11-29 |
Gtc生物治疗学公司 |
在转基因哺乳动物奶中生产融合蛋白的方法
|
EP2392655A3
(de)
|
2003-09-09 |
2012-02-29 |
Novo Nordisk Health Care AG |
Gerinnungsfaktor VII Polypeptide
|
US7297336B2
(en)
|
2003-09-12 |
2007-11-20 |
Baxter International Inc. |
Factor IXa specific antibodies displaying factor VIIIa like activity
|
US20050136103A1
(en)
*
|
2003-09-17 |
2005-06-23 |
Ben-Sasson Shmuel A. |
Compositions capable of facilitating penetration across a biological barrier
|
AU2004276306A1
(en)
*
|
2003-09-23 |
2005-04-07 |
Favrille, Inc. |
Altering a B cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent
|
UA89481C2
(uk)
|
2003-09-30 |
2010-02-10 |
Центокор, Инк. |
Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
|
WO2005031362A2
(en)
|
2003-10-02 |
2005-04-07 |
Ramot At Tel Aviv University Ltd. |
Novel antibacterial agents and methods of identifying and utilizing same
|
US7799518B2
(en)
|
2003-10-07 |
2010-09-21 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
US7418396B2
(en)
*
|
2003-10-14 |
2008-08-26 |
Broadcom Corporation |
Reduced memory implementation technique of filterbank and block switching for real-time audio applications
|
IN2014DN02483A
(de)
|
2003-10-24 |
2015-05-15 |
Selexis Sa |
|
IL158868A0
(en)
*
|
2003-11-13 |
2004-05-12 |
Yeda Res & Dev |
Methods of generating and using stem cells enriched with immature primitive progenitor
|
US20050125914A1
(en)
*
|
2003-11-18 |
2005-06-16 |
Gerard Malle |
Hair shaping composition comprising at least one- non-hydroxide base
|
JP4412989B2
(ja)
*
|
2003-12-15 |
2010-02-10 |
株式会社日立製作所 |
複数の記憶システムを有するデータ処理システム
|
DE10359661A1
(de)
*
|
2003-12-18 |
2005-07-28 |
Basf Ag |
Genvarianten die für Proteine aus dem Stoffwechselweg von Feinchemikalien codieren
|
CA2487098A1
(en)
*
|
2003-12-22 |
2005-06-22 |
F. Hoffmann-La Roche Ag |
Novel targets for obesity from fat tissue
|
US8007847B2
(en)
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
WO2005071058A2
(en)
*
|
2004-01-27 |
2005-08-04 |
Compugen Ltd. |
Methods and systems for annotating biomolecular sequences
|
US20050186608A1
(en)
*
|
2004-02-19 |
2005-08-25 |
Olsen Byron V. |
Method for the production of transgenic proteins useful in the treatment of obesity and diabetes
|
US20050197496A1
(en)
*
|
2004-03-04 |
2005-09-08 |
Gtc Biotherapeutics, Inc. |
Methods of protein fractionation using high performance tangential flow filtration
|
AU2005231359A1
(en)
*
|
2004-03-31 |
2005-10-20 |
Centocor, Inc. |
Human GLP-1 mimetibodies, compositions, methods and uses
|
NZ550106A
(en)
|
2004-04-22 |
2009-06-26 |
Kyowa Hakko Kirin Co Ltd |
Transgenic animals and uses thereof
|
US20050245444A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Yann Echelard |
Method of using recombinant human antithrombin for neurocognitive disorders
|
KR100646222B1
(ko)
|
2004-06-03 |
2006-11-23 |
대한민국 |
돼지 유선특이 발현벡터 및 이를 이용한 형질전환 동물 유선에서 유전자 발현방법
|
AU2005265098B2
(en)
|
2004-06-17 |
2012-02-23 |
Thrasos Innovation, Inc. |
TDF-related compounds and analogs thereof
|
WO2006012304A2
(en)
*
|
2004-06-25 |
2006-02-02 |
The Salk Institute For Biological Studies |
Increasing life span by modulation of smek
|
US8680062B2
(en)
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US20090156471A1
(en)
*
|
2004-07-15 |
2009-06-18 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
EP1781310B1
(de)
*
|
2004-08-02 |
2015-10-14 |
Ramot at Tel Aviv University Ltd. |
Artikel von peptidnanostrukturen und herstellungsverfahren dafür
|
WO2006017621A2
(en)
*
|
2004-08-02 |
2006-02-16 |
Janssen Pharmaceutica N.V. |
IRAK1c SPLICE VARIANT AND ITS USE
|
US7893197B2
(en)
*
|
2004-08-25 |
2011-02-22 |
Janssen Pharmaceutica N.V. |
Relaxin-3 chimeric polypeptides and their preparation and use
|
US7393662B2
(en)
*
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
WO2006027780A2
(en)
|
2004-09-08 |
2006-03-16 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
|
US20060063187A1
(en)
*
|
2004-09-15 |
2006-03-23 |
Hotamisligil Gokhan S |
Modulation of XBP-1 activity for treatment of metabolic disorders
|
EP1817333A4
(de)
*
|
2004-10-12 |
2008-12-31 |
Janssen Pharmaceutica Nv |
Cholecystokinin-1-rezeptormaterialien von hunden und ihre verwendung
|
JP4271122B2
(ja)
*
|
2004-10-15 |
2009-06-03 |
財団法人 ひろしま産業振興機構 |
カイコでの組換えタンパク質製造のためのポリヌクレオチド
|
CA2583121A1
(en)
|
2004-10-21 |
2007-01-04 |
Wyeth |
Immunogenic compositions of staphylococcus epidermidis polypeptide antigens
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
US20060121004A1
(en)
*
|
2004-12-07 |
2006-06-08 |
Yann Echelard |
Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
|
US20060130159A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Nick Masiello |
Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
|
CN1274829C
(zh)
|
2004-12-10 |
2006-09-13 |
四川大学华西医院 |
抗eb病毒所致肿瘤多肽及其应用与制备方法
|
US20060154285A1
(en)
*
|
2004-12-29 |
2006-07-13 |
Robishaw Janet D |
Zebrafish heterotrimer G-protein gamma 2 subunit (GNG2)
|
JP2008529325A
(ja)
*
|
2005-01-16 |
2008-07-31 |
ズランゴー リミテッド |
通信ネットワークシステムおよびそれを使用するための方法
|
US8375327B2
(en)
*
|
2005-01-16 |
2013-02-12 |
Zlango Ltd. |
Iconic communication
|
US8019818B2
(en)
*
|
2005-01-18 |
2011-09-13 |
Zlango Ltd. |
Communications network system and methods for using same
|
US20080019905A9
(en)
*
|
2005-02-18 |
2008-01-24 |
Strome Scott E |
Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
|
PE20061324A1
(es)
|
2005-04-29 |
2007-01-15 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, metodos y usos
|
KR20140090270A
(ko)
|
2005-05-09 |
2014-07-16 |
바이오스피어 메디칼 에스.에이. |
마이크로스피어 및 비이온성 조영제를 사용하는 조성물 및 방법
|
WO2006122224A1
(en)
|
2005-05-11 |
2006-11-16 |
Wayne State University |
Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance in pseudomonas aeruginosa
|
CA2608093A1
(en)
*
|
2005-05-11 |
2006-11-16 |
Wayne State University |
Novel targets for the identification of antibiotics that are not susceptible to antibiotic resistance
|
PL1899364T3
(pl)
|
2005-05-17 |
2020-08-24 |
University Of Connecticut |
Kompozycje i sposoby immunomodulacji w organizmie
|
CN101203603B
(zh)
|
2005-06-17 |
2011-11-16 |
巴斯福植物科学有限公司 |
凝集素样蛋白激酶胁迫相关多肽和在植物内使用的方法
|
WO2007052096A2
(en)
*
|
2005-06-29 |
2007-05-10 |
Cameron Malcolm Lang Clokie |
Production of bone morphogenic proteins (bmps) in transgenic mammals
|
JP2009501006A
(ja)
|
2005-06-30 |
2009-01-15 |
セントカー・インコーポレーテツド |
抗il−23抗体、組成物、方法および用途
|
EP1915448B1
(de)
|
2005-07-07 |
2013-09-04 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Nukleinsäuremittel zur herunterregulierung von h19 sowie verfahren zur verwendung davon
|
EP3138403A1
(de)
|
2005-08-09 |
2017-03-08 |
Revivicor, Inc. |
Ctla4-ig exprimierende transgene huftiere und verwendungen davon
|
JP5690047B2
(ja)
|
2005-09-14 |
2015-03-25 |
ノボ ノルディスク ヘルス ケア アーゲー |
ヒト凝固第vii因子ポリペプチド
|
EP1945258A4
(de)
|
2005-09-20 |
2011-08-17 |
Thrasos Therapeutics Inc |
Mit tdf verwandte verbindungen und analoga davon
|
AU2006297126A1
(en)
|
2005-09-30 |
2007-04-12 |
Government Of The United States Of America, As Represented By The Secretary |
Methods and compositions for modulating immune tolerance
|
JP2009510002A
(ja)
|
2005-09-30 |
2009-03-12 |
アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
反発誘導分子(rgm)タンパク質ファミリーのタンパク質の結合ドメイン、及びその機能的断片、及びそれらの使用
|
IL172297A
(en)
|
2005-10-03 |
2016-03-31 |
Compugen Ltd |
Soluble vegfr-1 variants for the diagnosis of preeclampsia
|
WO2007043048A2
(en)
*
|
2005-10-11 |
2007-04-19 |
Ramot At Tel Aviv University Ltd. |
Self-assembled fmoc-ff hydrogels
|
WO2007047859A2
(en)
|
2005-10-18 |
2007-04-26 |
Precision Biosciences |
Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity
|
DK1945666T3
(da)
*
|
2005-10-21 |
2013-07-01 |
Genzyme Corp |
Antistoffer med forøget antistofafhængig cellulær cytotoksicitetsaktivitet, fremgangsmåder til fremstilling af disse og anvendelse heraf
|
US20090291437A1
(en)
*
|
2005-11-02 |
2009-11-26 |
O'brien Sean |
Methods for targeting quadruplex sequences
|
US7767420B2
(en)
|
2005-11-03 |
2010-08-03 |
Momenta Pharmaceuticals, Inc. |
Heparan sulfate glycosaminoglycan lyase and uses thereof
|
US7879212B2
(en)
*
|
2005-11-03 |
2011-02-01 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructure-coated electrodes
|
WO2007078615A2
(en)
*
|
2005-12-15 |
2007-07-12 |
Cavit Sciences, Inc |
Methods and compositions for treatment of cancer
|
GB0525662D0
(en)
|
2005-12-16 |
2006-01-25 |
Glaxo Group Ltd |
Immunoglobulins
|
PL1971366T3
(pl)
|
2005-12-29 |
2015-01-30 |
Janssen Biotech Inc |
Ludzkie przeciwciała skierowane przeciw IL-23, kompozycje, sposoby i zastosowanie
|
IL173104A0
(en)
|
2006-01-12 |
2006-06-11 |
Yeda Res & Dev |
Siva and ubiquintination
|
EP1977312A2
(de)
|
2006-01-16 |
2008-10-08 |
Zlango Ltd. |
Bildzeichenkommunikation
|
WO2007080597A2
(en)
|
2006-01-16 |
2007-07-19 |
Compugen Ltd. |
Polynucleotide and polypeptide sequences and methods for diagnosis
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US7553941B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US20090221072A1
(en)
*
|
2006-02-15 |
2009-09-03 |
Chen Thomas T |
Compositions and methods for modulating cell differentiation
|
US7531632B2
(en)
*
|
2006-02-16 |
2009-05-12 |
Gtc Biotherapeutics, Inc. |
Clarification of transgenic milk using depth filtration
|
US7807364B2
(en)
|
2006-03-03 |
2010-10-05 |
University Of Southern California |
Angiogenesis pathway gene polymorphisms for therapy selection
|
WO2007115148A2
(en)
*
|
2006-03-31 |
2007-10-11 |
Centocor, Inc. |
Human mimetic epo hinge core mimetibodies
|
WO2007127151A2
(en)
*
|
2006-04-24 |
2007-11-08 |
The Cleveland Clinic Foundation |
Non-human model of autoimmune disease
|
US20080118979A1
(en)
|
2006-05-15 |
2008-05-22 |
Paratek Pharmaceuticals, Inc. |
Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
|
AU2007257162A1
(en)
|
2006-06-05 |
2007-12-13 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
US8124831B2
(en)
*
|
2006-07-06 |
2012-02-28 |
Duke University |
Transgenic mice carrying functional single nucleotide polymorphisms in brain-specific tryptophan hydroxylase
|
EP2471809B1
(de)
|
2006-07-11 |
2015-09-02 |
University Of Medicine And Dentistry Of New Jersey |
Proteine, Nukleinsäuren zu deren Kodierung und entsprechende Verwendungsverfahren
|
CA2659809A1
(en)
*
|
2006-08-04 |
2008-02-14 |
Pharmathene Inc. |
Long half-life recombinant butyrylcholinesterase
|
US9277737B2
(en)
|
2006-09-21 |
2016-03-08 |
Probiodrug Ag |
Mouse models carrying a knock-out mutation of the QPCTL-gene
|
EP2099467B1
(de)
|
2006-10-03 |
2017-05-10 |
University Of Medicine And Dentistry Of New Jersey |
Atap-proteine, für diese kodierende nukleinsäuren und entsprechende verwendungsverfahren
|
US9018440B2
(en)
*
|
2006-10-27 |
2015-04-28 |
Stowers Institute For Medical Research |
Fluorescent mouse model
|
TW200843794A
(en)
*
|
2006-12-21 |
2008-11-16 |
Centocor Inc |
Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles
|
CA2675967A1
(en)
*
|
2007-01-16 |
2008-07-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M |
Nucleic acid constructs and methods for specific silencing of h19
|
CA2675366A1
(en)
*
|
2007-01-18 |
2008-07-24 |
University Of Southern California |
Gene polymorphisms predictive for dual tki therapy
|
AU2008206936B2
(en)
|
2007-01-19 |
2013-03-14 |
Probiodrug Ag |
In vivo screening models for treatment of Alzheimer's disease and other Qpct-related disorders
|
WO2008093331A1
(en)
*
|
2007-01-29 |
2008-08-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Antibody conjugates for circumventing multi-drug resistance
|
EP2243834A1
(de)
|
2007-03-05 |
2010-10-27 |
Cancer Care Ontario |
Abschätzung des Kolorektalkarzinomrisikos
|
EP2134365B1
(de)
|
2007-03-21 |
2019-03-13 |
Effat Emamian |
Zusammensetzung und verfahren zur hemmung von zellwachstum
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
PT2144633E
(pt)
*
|
2007-04-23 |
2014-10-27 |
Deliversir Ltd |
Um sistema para a administração de agentes terapêuticos em células vivas e núcleos de células
|
US20110091378A1
(en)
|
2007-07-23 |
2011-04-21 |
Paul Dudas |
Methods and Compositions for Treating Fibrosis Related Disorders Using IL-17 Antagonists
|
LT2769729T
(lt)
|
2007-09-04 |
2019-05-10 |
Compugen Ltd. |
Polipeptidai ir polinukleotidai ir jų panaudojimas kaip vaistų taikinio vaistų ir biologinių preparatų gamybai
|
CN101802000A
(zh)
*
|
2007-09-12 |
2010-08-11 |
前体生物药物股份公司 |
转基因小鼠
|
HUE052423T2
(hu)
|
2007-09-28 |
2021-04-28 |
Alexion Pharma Inc |
Az XA faktor inhibitorok antidótumai és ezek alkalmazási módszerei
|
WO2009055656A2
(en)
|
2007-10-26 |
2009-04-30 |
Centocor, Inc. |
Vectors, host cells, and methods of production and uses
|
WO2009059195A2
(en)
|
2007-10-31 |
2009-05-07 |
Precision Biosciences |
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
|
EP2222709B1
(de)
|
2007-11-30 |
2016-11-23 |
Glaxo Group Limited |
Antigenbindende konstrukte
|
US8501449B2
(en)
|
2007-12-04 |
2013-08-06 |
Proteon Therapeutics, Inc. |
Recombinant elastase proteins and methods of manufacturing and use thereof
|
KR100912038B1
(ko)
|
2007-12-31 |
2009-08-12 |
전남대학교산학협력단 |
돼지 β-카제인 게놈 DNA, 및 이를 포함하는 재조합벡터 및 형질전환체
|
EP2238252B1
(de)
*
|
2008-01-14 |
2013-07-31 |
Probiodrug AG |
Mausmodelle mit einer knockout-mutation des glutaminyl-cyclase-gens
|
AU2009208607B2
(en)
*
|
2008-01-31 |
2013-08-01 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
CA2717320A1
(en)
|
2008-03-11 |
2009-09-17 |
Sequenom, Inc. |
Nucleic acid-based tests for prenatal gender determination
|
EP2279003A4
(de)
*
|
2008-05-01 |
2013-04-03 |
Gtc Biotherapeutics Inc |
Anti-cd137-antikörper als mittel zur behandlung von entzündlichen erkrankungen
|
WO2009155484A2
(en)
|
2008-06-20 |
2009-12-23 |
Wyeth |
Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains
|
JP5507555B2
(ja)
*
|
2008-06-30 |
2014-05-28 |
チョ−エー・ファーム・カンパニー・リミテッド |
豚のαS1カゼイン遺伝子、そのプロモーター、及びその用途
|
CA2729623C
(en)
*
|
2008-06-30 |
2014-06-10 |
Cho-A Pharm Co., Ltd. |
A gene of porcine beta-casein, a promoter of the same and the use thereof
|
WO2010014222A1
(en)
|
2008-07-30 |
2010-02-04 |
Dana-Farber Cancer Institute, Inc. |
Compositions for detecting cell death and methods of use thereof
|
AR073060A1
(es)
|
2008-08-14 |
2010-10-13 |
Arana Therapeutic Ltd |
Anticuerpos anti-il-12/il-23
|
US20110237496A1
(en)
|
2008-09-10 |
2011-09-29 |
Ilana Nathan |
Antinecrotic activity of alpha 1-antitrypsin
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
CN102264762B
(zh)
|
2008-09-26 |
2018-03-27 |
达纳-法伯癌症研究公司 |
人抗pd‑1、pd‑l1和pd‑l2的抗体及其应用
|
EP3335728B8
(de)
|
2008-10-10 |
2020-03-11 |
Children's Medical Center Corporation |
Biochemisch stabilisierter hiv-1-env-trimer-impfstoff
|
WO2010061393A1
(en)
|
2008-11-30 |
2010-06-03 |
Compugen Ltd. |
He4 variant nucleotide and amino acid sequences, and methods of use thereof
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
EP2633854B1
(de)
|
2008-12-05 |
2015-09-16 |
Yeda Research And Development Co. Ltd. |
miRNA-9 or miRNA-9* zur Verwendung in der Behandlung von ALS
|
WO2010080985A1
(en)
|
2009-01-08 |
2010-07-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
US8530629B2
(en)
|
2009-01-30 |
2013-09-10 |
Ab Biosciences, Inc. |
Lowered affinity antibodies and uses therefor
|
US8362203B2
(en)
*
|
2009-02-10 |
2013-01-29 |
Wayne State University |
Non-natural peptides as models for the development of antibiotics
|
CA2753287A1
(en)
|
2009-02-24 |
2010-09-02 |
Glaxo Group Limited |
Antigen-binding constructs
|
CA2753263A1
(en)
|
2009-02-24 |
2010-09-02 |
Glaxo Group Limited |
Multivalent and/or multispecific rankl-binding constructs
|
CA2753332A1
(en)
|
2009-02-24 |
2010-09-02 |
Glaxo Group Limited |
Antigen-binding constructs
|
WO2010117729A1
(en)
|
2009-03-30 |
2010-10-14 |
Portola Pharmaceuticals, Inc. |
Antidotes for factor xa inhibitors and methods of using the same
|
WO2010115786A1
(en)
|
2009-04-01 |
2010-10-14 |
Glaxo Group Limited |
Anti-il-23 immunoglobulins
|
WO2010122090A1
(en)
|
2009-04-24 |
2010-10-28 |
Glaxo Group Limited |
Fgfr1c antibody combinations
|
US9023767B2
(en)
*
|
2009-05-07 |
2015-05-05 |
Memorial Sloan-Kettering Cancer Center |
γ-Secretase substrates and methods of use
|
CA2762404A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Probiodrug Ag |
Mouse models carrying a knock-out mutation of the qpctl-gene
|
US20100304873A1
(en)
*
|
2009-05-28 |
2010-12-02 |
Lipa Markowitz |
Bowling Ball and Football Game Controller
|
US8435961B2
(en)
*
|
2009-06-26 |
2013-05-07 |
Massachusetts Institute Of Technology |
Methods and compositions for increasing the activity of inhibitory RNA
|
US20110097329A1
(en)
|
2009-06-26 |
2011-04-28 |
Massachusetts Institute Of Technology |
Compositions and methods for treating cancer and modulating stress granule formation
|
US8268550B2
(en)
*
|
2009-06-26 |
2012-09-18 |
Massachusetts Institute Of Technology |
Compositions and methods for identification of PARP function, inhibitors, and activators
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
JP6163304B2
(ja)
|
2009-07-15 |
2017-07-12 |
ポートラ ファーマシューティカルズ, インコーポレイテッド |
第Xa因子インヒビターの解毒剤の単位用量処方物およびその使用方法
|
CN102712687A
(zh)
*
|
2009-07-17 |
2012-10-03 |
丹麦国家医院 |
作为补体激活的抑制剂的masp同种型
|
US9642817B2
(en)
|
2009-08-27 |
2017-05-09 |
Technion Research & Development Foundation Limited |
Liposomal compositions and uses of same
|
JP2013510158A
(ja)
|
2009-11-03 |
2013-03-21 |
グリフオルス・セラピユーテイクス・インコーポレーテツド |
α‐1プロテイナーゼインヒビターのための組成物、方法およびキット
|
EP3168232B1
(de)
|
2009-11-13 |
2021-09-29 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzungen, kits und verfahren zur diagnose, prognose, überwachung, behandlung und modulierung von auf transplantationen folgenden lymphoproliferativen erkrankungen und hypoxievermittelten angiogeneseerkrankungen mithilfe von galectin-1
|
BR112012012460B1
(pt)
|
2009-11-24 |
2020-06-23 |
Grifols Therapeutics Inc. |
Método de liofilização de uma composição
|
MX2012006560A
(es)
|
2009-12-08 |
2012-10-05 |
Abbott Gmbh & Co Kg |
Anticuerpos monoclonales contra la proteina rgm a para utilizarse en el tratamiento de degeneracion de capa de fibra de nervio retinal.
|
JP2013526840A
(ja)
|
2009-12-21 |
2013-06-27 |
ファーマシーネ,インコーポレイテッド |
組み換えブチリルコリンエステラーゼおよびその切断型
|
US9926593B2
(en)
|
2009-12-22 |
2018-03-27 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
US9745589B2
(en)
|
2010-01-14 |
2017-08-29 |
Cornell University |
Methods for modulating skeletal remodeling and patterning by modulating SHN2 activity, SHN3 activity, or SHN2 and SHN3 activity in combination
|
JP2013520162A
(ja)
|
2010-01-22 |
2013-06-06 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
代謝障害の同定、査定、予防および治療のための組成物、キットおよび方法
|
CA2787311C
(en)
|
2010-01-27 |
2017-08-15 |
Yeda Research And Development Co. Ltd. |
Antibodies that inhibit metalloproteins
|
EP2528948B1
(de)
|
2010-01-28 |
2018-09-19 |
AB Biosciences, Inc. |
Neue antikörper mit reduzierter affinität und verfahren zu ihrer herstelung
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
MX341687B
(es)
|
2010-02-10 |
2016-08-30 |
Immunogen Inc |
"anticuerpos cd20 y su utilización".
|
CA2791058A1
(en)
|
2010-02-24 |
2011-09-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
CA2791841C
(en)
|
2010-03-05 |
2023-01-03 |
Rigshospitalet |
Chimeric inhibitor molecules of complement activation
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
CN107098958B
(zh)
|
2010-03-26 |
2021-11-05 |
达特茅斯大学理事会 |
Vista调节性t细胞介体蛋白、vista结合剂及其用途
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US9115345B2
(en)
|
2010-04-19 |
2015-08-25 |
The Trustees Of The University Of Pennsylvania |
MicroRNA induction of pluripotential stem cells and uses thereof
|
AU2011268110B2
(en)
|
2010-06-19 |
2016-05-19 |
Memorial Sloan-Kettering Cancer Center |
Anti-GD2 antibodies
|
EP2588123A2
(de)
|
2010-06-30 |
2013-05-08 |
Compugen Ltd. |
C1orf32 zur behandlung von multipler sklerose, rheumatoider arthritis und anderen autoimmunerkrankungen
|
JP2013541938A
(ja)
|
2010-09-02 |
2013-11-21 |
プロビオドルグ エージー |
アイソqc関連障害の治療のためのインビボスクリーニングモデル
|
CN103502466A
(zh)
|
2010-09-07 |
2014-01-08 |
斯隆-凯特林纪念癌症中心 |
用于γ-分泌酶测定的方法和组合物
|
WO2012046238A2
(en)
|
2010-10-06 |
2012-04-12 |
Ramot At Tel-Aviv University Ltd. |
Erythropoietin receptor antagonists
|
WO2012051301A1
(en)
|
2010-10-12 |
2012-04-19 |
President And Fellows Of Harvard College |
Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
WO2012064743A2
(en)
|
2010-11-08 |
2012-05-18 |
The Johns Hopkins University |
Methods for improving heart function
|
WO2012066549A1
(en)
|
2010-11-15 |
2012-05-24 |
Ramot At Tel-Aviv University Ltd. |
Dipeptide analogs for treating conditions associated with amyloid fibril formation
|
PT2643352T
(pt)
|
2010-11-23 |
2018-08-01 |
Glaxo Group Ltd |
Proteínas de ligação a antigénio para a oncostatina m (osm)
|
WO2012069557A1
(en)
|
2010-11-24 |
2012-05-31 |
Glaxo Group Limited |
Multispecific antigen binding proteins targeting hgf
|
EP3153583B1
(de)
|
2010-12-31 |
2021-10-20 |
BioAtla, Inc. |
Express-humanisierung von antikörpern
|
US8974782B2
(en)
|
2011-02-07 |
2015-03-10 |
Glaxo Group Limited |
Treatment of stroke comprising anti-MAG antibodies
|
WO2012109238A2
(en)
|
2011-02-07 |
2012-08-16 |
President And Fellows Of Harvard College |
Methods for increasing immune responses using agents that directly bind to and activate ire-1
|
CN102643852B
(zh)
|
2011-02-28 |
2015-04-08 |
华东理工大学 |
光可控的基因表达系统
|
RU2016147206A
(ru)
|
2011-04-15 |
2018-10-19 |
Компуджен Лтд. |
Полипептиды и полинуклеотиды и их применение для лечения иммунологических нарушений и рака
|
CA2834218C
(en)
|
2011-04-29 |
2021-02-16 |
Sequenom, Inc. |
Quantification of a minority nucleic acid species using inhibitory oligonucleotides
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
ES2931180T3
(es)
|
2011-05-19 |
2022-12-27 |
Fund Publica Andaluza Progreso Y Salud |
Sistema de tipo Tet-on lentivírico de promotor dual muy inducible
|
TWI560200B
(en)
|
2011-05-25 |
2016-12-01 |
Innate Pharma Sa |
Anti-kir antibodies for the treatment of inflammatory and autoimmune disorders
|
LT3415531T
(lt)
|
2011-05-27 |
2023-09-25 |
Glaxo Group Limited |
Bcma (cd269/tnfrsf17) – surišantys baltymai
|
EP2726503B1
(de)
|
2011-06-30 |
2019-09-04 |
Compugen Ltd. |
Polypetide und ihre verwendung zur behandlung von autoimmunerkrankungen und infektionen
|
KR101632620B1
(ko)
|
2011-07-27 |
2016-06-23 |
글락소 그룹 리미티드 |
Fc 도메인에 융합된 항vegf 단일 가변 도메인
|
WO2013024043A2
(en)
|
2011-08-12 |
2013-02-21 |
Probiodrug Ag |
In vivo screening models for treatment of qc-related disorders
|
EP3564261A1
(de)
|
2011-08-23 |
2019-11-06 |
Foundation Medicine, Inc. |
Kif5b-re-fusionsmoleküle und verwendungen davon
|
US10093705B2
(en)
|
2011-09-13 |
2018-10-09 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using FNDC5
|
US10378060B2
(en)
|
2011-10-14 |
2019-08-13 |
Dana-Farber Cancer Institute, Inc. |
ZNF365/ZFP365 biomarker predictive of anti-cancer response
|
EP3984551A1
(de)
|
2011-12-02 |
2022-04-20 |
Rhode Island Hospital |
Impfstoff gegen falciparum-malaria
|
US10118958B2
(en)
|
2011-12-14 |
2018-11-06 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
WO2013090633A2
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
EP2793936A4
(de)
*
|
2011-12-19 |
2015-05-27 |
Lfb Usa Inc |
Rekombinantes menschliches alpha-1-antitrypsin zur behandlung von entzündungskrankheiten
|
PL2807192T3
(pl)
|
2012-01-27 |
2019-02-28 |
Abbvie Deutschland |
Kompozycja oraz sposób diagnostyki i leczenia chorób związanych ze zwyrodnieniem neurytów
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
KR20140126357A
(ko)
|
2012-02-01 |
2014-10-30 |
컴퓨젠 엘티디. |
C1orf32 항체 및 이의 암 치료를 위한 용도
|
SG10201606195UA
(en)
|
2012-02-09 |
2016-09-29 |
Var2 Pharmaceuticals Aps |
Targeting of chondroitin sulfate glycans
|
MY172539A
(en)
|
2012-02-14 |
2019-11-30 |
Opko Biologics Ltd |
Long-acting coagulation factors and methods of producing same
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
EP2814844B1
(de)
|
2012-02-15 |
2017-08-02 |
Novo Nordisk A/S |
Antikörper, die den auslösenden rezeptor binden und blockieren, der auf myeloid-zellen-1 (trem-1) exprimiert ist
|
CN104203977A
(zh)
|
2012-02-15 |
2014-12-10 |
诺和诺德A/S(股份有限公司) |
结合肽聚糖识别蛋白1的抗体
|
ES2930180T3
(es)
|
2012-03-02 |
2022-12-07 |
Sequenom Inc |
Métodos para enriquecer ácido nucleico canceroso a partir de una muestra biológica
|
AU2013234046B2
(en)
|
2012-03-16 |
2017-09-07 |
University Health Network |
Methods and compositions for modulating Toso activity
|
US9494597B2
(en)
|
2012-04-02 |
2016-11-15 |
Ab Biosciences, Inc. |
Human control antibodies and uses therefor
|
MY167814A
(en)
|
2012-04-19 |
2018-09-26 |
Opko Biologics Ltd |
Long-acting oxyntomodulin variants and methods of producing same
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
CN104603149B
(zh)
|
2012-05-24 |
2017-06-30 |
万机集团有限公司 |
与预防和治疗狂犬病感染相关的组合物和方法
|
CN104619722B
(zh)
|
2012-06-22 |
2022-10-04 |
达特茅斯大学理事会 |
新型vista-ig构建体和vista-ig用于治疗自身免疫性、过敏性和炎性疾病的用途
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
EP2872648B1
(de)
|
2012-07-13 |
2019-09-04 |
Sequenom, Inc. |
Verfahren und zusammensetzungen zur methylierungsbasierten anreicherung fetaler nukleinsäure aus einer mütterlichen probe für nicht-invasive pränatale diagnosen
|
KR20150039201A
(ko)
|
2012-08-03 |
2015-04-09 |
엘에프비 유에스에이, 인크. |
체외 막 산소공급에서의 안티트롬빈의 용도
|
WO2014029752A1
(en)
|
2012-08-22 |
2014-02-27 |
Glaxo Group Limited |
Anti lrp6 antibodies
|
JP6368308B2
(ja)
|
2012-09-07 |
2018-08-01 |
トラスティーズ・オブ・ダートマス・カレッジ |
癌の診断および治療のためのvista調節剤
|
JP2015532307A
(ja)
|
2012-10-15 |
2015-11-09 |
ノヴォ・ノルディスク・ヘルス・ケア・アーゲー |
凝固因子viiポリペプチド
|
AU2013336237A1
(en)
|
2012-10-22 |
2015-06-11 |
Sabag-Rfa Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
CN104870477B
(zh)
|
2012-10-23 |
2018-10-09 |
爱默蕾大学 |
Gm-csf和il-4轭合物、组合物以及与其相关的方法
|
EP2914621B1
(de)
|
2012-11-05 |
2023-06-07 |
Foundation Medicine, Inc. |
Neuartige ntrk1-fusionsmoleküle und verwendungen davon
|
BR122020018510B1
(pt)
|
2012-11-20 |
2023-03-14 |
Opko Biologics Ltd |
Método para aumentar incrementalmente o tamanho hidrodinâmico de um fator de coagulação ativado viia
|
EP3252160B1
(de)
|
2012-12-12 |
2020-10-28 |
The Broad Institute, Inc. |
Systeme, verfahren und zusammensetzungen mit crispr-cas-komponenten zur sequenzmanipulation
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
EP2848690B1
(de)
|
2012-12-12 |
2020-08-19 |
The Broad Institute, Inc. |
Systeme, Verfahren und Zusammensetzungen mit CRISPR-Cas-Komponenten zur Sequenzmanipulation
|
EP2931899A1
(de)
|
2012-12-12 |
2015-10-21 |
The Broad Institute, Inc. |
Funktionale genomik unter verwendung von crispr-cas systemen, zusammensetzungen, verfahren, knockout-bibliotheken und anwendungen davon
|
WO2014093694A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
|
DK2931898T3
(en)
|
2012-12-12 |
2016-06-20 |
Massachusetts Inst Technology |
CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH FUNCTIONAL DOMAINS
|
ES2553782T3
(es)
|
2012-12-12 |
2015-12-11 |
The Broad Institute, Inc. |
Ingeniería de sistemas, métodos y composiciones de guía optimizadas para manipulación de secuencias
|
ES2786193T3
(es)
|
2012-12-12 |
2020-10-09 |
Broad Inst Inc |
Modificación por tecnología genética y optimización de sistemas, métodos y composiciones enzimáticas mejorados para la manipulación de secuencias
|
MX2015007550A
(es)
|
2012-12-12 |
2017-02-02 |
Broad Inst Inc |
Suministro, modificación y optimización de sistemas, métodos y composiciones para la manipulación de secuencias y aplicaciones terapéuticas.
|
EP3434776A1
(de)
|
2012-12-12 |
2019-01-30 |
The Broad Institute, Inc. |
Verfahren, modelle, systeme und vorrichtungen zur identifikation von zielsequenzen für cas-enzyme oder crispr-cas-systeme für zielsequenzen und förderresultate davon
|
WO2014113729A2
(en)
|
2013-01-18 |
2014-07-24 |
Foundation Mecicine, Inc. |
Methods of treating cholangiocarcinoma
|
JP2016505640A
(ja)
|
2013-01-28 |
2016-02-25 |
ソレイ リミテッド ライアビリティ カンパニー |
満腹ホルモン放出活性を有する新規なポリペプチド
|
BR112015019348A2
(pt)
|
2013-02-13 |
2017-08-22 |
Lab Francais Du Fractionnement |
Métodos para produção de proteína com glicosilação modificada e com sialilação aumentada, para aumentar a atividade de sialil transferase na glândula mamária e para produzir sialil transferase, proteína com glicosilação modificada ou proteína com sialilação aumentada, composição, sialil transferase, mamífero transgênico, e, célula epitelial mamária
|
MX2015010427A
(es)
|
2013-02-13 |
2016-03-17 |
Lab Francais Du Fractionnement |
Anticuerpos anti-tnf-alfa altamente galactosilados y sus usos.
|
US11060145B2
(en)
|
2013-03-13 |
2021-07-13 |
Sequenom, Inc. |
Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
|
CN105705165B
(zh)
|
2013-03-15 |
2020-04-24 |
纪念斯隆-凯特琳癌症中心 |
高亲和力抗gd2抗体
|
AU2014230741B2
(en)
|
2013-03-15 |
2017-04-13 |
Glaxosmithkline Intellectual Property Development Limited |
Anti-LAG-3 binding proteins
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
EP3003372B1
(de)
|
2013-06-07 |
2019-10-09 |
Duke University |
Inhibitoren des komplementfaktors h
|
ES2777217T3
(es)
|
2013-06-17 |
2020-08-04 |
Broad Inst Inc |
Suministro, modificación y optimización de sistemas de guía en tándem, métodos y composiciones para la manipulación de secuencias
|
EP3011033B1
(de)
|
2013-06-17 |
2020-02-19 |
The Broad Institute, Inc. |
Funktionale genomik unter verwendung von crispr-cas-systemen, zusammensetzungen, verfahren, schirme und anwendungen davon
|
DK3011031T3
(da)
|
2013-06-17 |
2020-12-21 |
Broad Inst Inc |
Fremføring og anvendelse af crispr-cas-systemerne, vektorer og sammensætninger til levermålretning og -terapi
|
KR20160034901A
(ko)
|
2013-06-17 |
2016-03-30 |
더 브로드 인스티튜트, 인코퍼레이티드 |
서열 조작에 최적화된 crispr-cas 이중 닉카아제 시스템, 방법 및 조성물
|
DK3011032T3
(da)
|
2013-06-17 |
2020-01-20 |
Broad Inst Inc |
Fremføring, modificering og optimering af systemer, fremgangsmåder og sammensætninger til målretning mod og modellering af sygdomme og forstyrrelser i postmitotiske celler
|
SG11201510286QA
(en)
|
2013-06-17 |
2016-01-28 |
Broad Inst Inc |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using viral components
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
US9340800B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
Extended DNA-sensing GRNAS
|
ES2724300T3
(es)
|
2013-09-25 |
2019-09-10 |
Univ Cornell |
Compuestos para inducir inmunidad antitumoral y métodos de lo mismo
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
AU2014338575B2
(en)
|
2013-10-21 |
2019-11-07 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
WO2015065964A1
(en)
|
2013-10-28 |
2015-05-07 |
The Broad Institute Inc. |
Functional genomics using crispr-cas systems, compositions, methods, screens and applications thereof
|
EP2876114A1
(de)
|
2013-11-25 |
2015-05-27 |
Consejo Superior De Investigaciones Científicas |
Antikörper gegen CCR9 und Anwendungen davon
|
JP6625055B2
(ja)
|
2013-12-12 |
2020-01-08 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
組成物、及びヌクレオチドリピート障害におけるcrispr−cas系の使用方法
|
DK3079725T3
(da)
|
2013-12-12 |
2020-01-20 |
Broad Inst Inc |
Administration, brug og terapeutiske anvendelser af crispr-cas-systemerne og sammensætninger til genomredigering
|
WO2015089486A2
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
|
KR20160089526A
(ko)
|
2013-12-12 |
2016-07-27 |
더 브로드 인스티튜트, 인코퍼레이티드 |
입자 전달 성분을 이용한 표적 장애 및 질병에 대한 crispr-cas 시스템 및 조성물의 전달, 이용 및 치료 적용
|
WO2015089364A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Crystal structure of a crispr-cas system, and uses thereof
|
EP4219699A1
(de)
|
2013-12-12 |
2023-08-02 |
The Broad Institute, Inc. |
Konstruktion von systemen, verfahren und optimierten führungszusammensetzungen mit neuen architekturen zur sequenzmanipulation
|
CN111269902A
(zh)
|
2013-12-12 |
2020-06-12 |
布罗德研究所有限公司 |
Crispr-cas系统和组合物的递送及用途
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
DK3087098T3
(da)
|
2013-12-24 |
2020-06-08 |
Janssen Pharmaceutica Nv |
Anti-Vista-antistoffer og -fragmenter
|
CA2936258A1
(en)
|
2014-02-07 |
2015-08-13 |
Medimmune, Llc |
Novel assay to detect human periostin
|
AU2015225867B2
(en)
|
2014-03-07 |
2020-02-06 |
University Health Network |
Methods and compositions for modifying the immune response
|
EP3736344A1
(de)
|
2014-03-13 |
2020-11-11 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
US11624093B2
(en)
|
2014-04-24 |
2023-04-11 |
Dana-Farber Cancer Institute, Inc. |
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
|
CA2948462A1
(en)
|
2014-05-15 |
2015-11-19 |
National University Of Singapore |
Modified natural killer cells and uses thereof
|
WO2015175889A1
(en)
|
2014-05-16 |
2015-11-19 |
The Trustees Of The University Of Pennsylvania |
Microrna induction of cardiac regeneration
|
CA2951885C
(en)
|
2014-06-11 |
2023-07-04 |
Kathy A. Green |
Use of vista agonists and antagonists to suppress or enhance humoral immunity
|
ES2788426T3
(es)
|
2014-06-16 |
2020-10-21 |
Univ Johns Hopkins |
Composiciones y métodos para la expresión de ARNs de guía de CRISPR utilizando el promotor de H1
|
CN106536559B
(zh)
|
2014-07-17 |
2021-04-27 |
诺和诺德股份有限公司 |
定点诱变trem-1抗体以降低黏度
|
WO2016022363A2
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
EP3686279B1
(de)
|
2014-08-17 |
2023-01-04 |
The Broad Institute, Inc. |
Genombearbeitung mit cas9-nickasen
|
US20170275344A1
(en)
|
2014-08-26 |
2017-09-28 |
Compugen Ltd. |
Polypeptides and uses thereof as a drug for treatment of autoimmune disorders
|
WO2016049163A2
(en)
|
2014-09-24 |
2016-03-31 |
The Broad Institute Inc. |
Use and production of chd8+/- transgenic animals with behavioral phenotypes characteristic of autism spectrum disorder
|
WO2016049251A1
(en)
|
2014-09-24 |
2016-03-31 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling mutations in leukocytes
|
WO2016049024A2
(en)
|
2014-09-24 |
2016-03-31 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling competition of multiple cancer mutations in vivo
|
WO2016049258A2
(en)
|
2014-09-25 |
2016-03-31 |
The Broad Institute Inc. |
Functional screening with optimized functional crispr-cas systems
|
US20170248603A1
(en)
|
2014-10-06 |
2017-08-31 |
Dana-Farber Cancer Institute, Inc. |
Angiopoiten-2 biomarkers predictive of anti-immune checkpoint response
|
AU2015357463B2
(en)
|
2014-12-05 |
2021-10-07 |
Immunext, Inc. |
Identification of VSIG8 as the putative vista receptor and its use thereof to produce vista/VSIG8 modulators
|
TWI746427B
(zh)
|
2014-12-10 |
2021-11-21 |
以色列商歐科生物製品有限公司 |
製造長效ctp修飾的多肽之方法
|
WO2016094867A1
(en)
|
2014-12-12 |
2016-06-16 |
The Broad Institute Inc. |
Protected guide rnas (pgrnas)
|
EP3230452A1
(de)
|
2014-12-12 |
2017-10-18 |
The Broad Institute Inc. |
Totführungen für crispr-transkriptionsfaktoren
|
WO2016094880A1
(en)
|
2014-12-12 |
2016-06-16 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of crispr systems and compositions for genome editing as to hematopoietic stem cells (hscs)
|
WO2016094874A1
(en)
|
2014-12-12 |
2016-06-16 |
The Broad Institute Inc. |
Escorted and functionalized guides for crispr-cas systems
|
WO2016100974A1
(en)
|
2014-12-19 |
2016-06-23 |
The Broad Institute Inc. |
Unbiased identification of double-strand breaks and genomic rearrangement by genome-wide insert capture sequencing
|
WO2016106236A1
(en)
|
2014-12-23 |
2016-06-30 |
The Broad Institute Inc. |
Rna-targeting system
|
CA2970370A1
(en)
|
2014-12-24 |
2016-06-30 |
Massachusetts Institute Of Technology |
Crispr having or associated with destabilization domains
|
MA41296A
(fr)
|
2014-12-30 |
2017-11-07 |
Orgenesis Ltd |
Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
|
WO2016108926A1
(en)
|
2014-12-30 |
2016-07-07 |
The Broad Institute Inc. |
Crispr mediated in vivo modeling and genetic screening of tumor growth and metastasis
|
AU2016229238B2
(en)
|
2015-03-06 |
2022-06-02 |
Dana-Farber Cancer Institute, Inc. |
PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers
|
EP3271398B1
(de)
|
2015-03-17 |
2022-08-31 |
Memorial Sloan Kettering Cancer Center |
Anti-muc16-antikörper und verwendungen davon
|
EP4218771A1
(de)
|
2015-03-27 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Verfahren zur behandlung von motoneuronenerkrankungen
|
US20180161300A1
(en)
|
2015-05-11 |
2018-06-14 |
Yeda Research And Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
WO2016205728A1
(en)
|
2015-06-17 |
2016-12-22 |
Massachusetts Institute Of Technology |
Crispr mediated recording of cellular events
|
WO2016205745A2
(en)
*
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Cell sorting
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
WO2016205749A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
FI3430134T3
(fi)
|
2015-06-18 |
2023-01-13 |
|
Uusia CRISPR-entsyymejä ja järjestelmiä
|
ES2893616T3
(es)
|
2015-06-19 |
2022-02-09 |
Opko Biologics Ltd |
Factores de coagulación de acción prolongada y métodos para la producción de los mismos
|
US11009509B2
(en)
|
2015-06-24 |
2021-05-18 |
Janssen Pharmaceutica Nv |
Anti-VISTA antibodies and fragments
|
US10287338B2
(en)
|
2015-07-10 |
2019-05-14 |
Miran NERSISSIAN |
Factor VIII protein compositions and methods of treating of hemophilia A
|
EP3328429A4
(de)
|
2015-07-31 |
2019-03-20 |
The Research Institute at Nationwide Children's Hospital |
Peptide und antikörper zur beseitigung von biofilmen
|
WO2017024317A2
(en)
|
2015-08-06 |
2017-02-09 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
US10639350B2
(en)
|
2015-08-10 |
2020-05-05 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using CD24
|
ES2842306T3
(es)
|
2015-09-02 |
2021-07-13 |
Immutep Sas |
Anticuerpos anti LAG-3
|
WO2017066719A2
(en)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Hu specific interfering agents
|
CN109153980B
(zh)
|
2015-10-22 |
2023-04-14 |
布罗德研究所有限公司 |
Vi-b型crispr酶和系统
|
IL258821B
(en)
|
2015-10-23 |
2022-07-01 |
Harvard College |
Nucleobase editors and their uses
|
WO2017075329A2
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
EP3373939A4
(de)
|
2015-11-10 |
2019-06-26 |
B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University |
Mittel und verfahren zur verringerung der tumorigenität von krebsstammzellen
|
WO2017106657A1
(en)
|
2015-12-18 |
2017-06-22 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
US10465003B2
(en)
|
2016-02-05 |
2019-11-05 |
Janssen Biotech, Inc. |
Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
|
TW202216201A
(zh)
|
2016-02-12 |
2022-05-01 |
比利時商楊森製藥公司 |
抗vista抗體及片段、其用途及鑑定其之方法
|
US20190046497A1
(en)
|
2016-02-14 |
2019-02-14 |
Yeda Research And Development Co., Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
CA3019164A1
(en)
|
2016-03-29 |
2017-10-05 |
Janssen Biotech, Inc. |
Method of treating psoriasis with increased interval dosing of anti-il12/23 antibody
|
CA3018305A1
(en)
|
2016-03-30 |
2017-10-05 |
Regentis Biomaterials Ltd. |
Treatments utilizing a polymer-protein conjugate
|
WO2017175058A1
(en)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
CN117562992A
(zh)
|
2016-04-15 |
2024-02-20 |
伊穆奈克斯特股份有限公司 |
抗人vista抗体及其用途
|
SG10202010311SA
(en)
|
2016-04-19 |
2020-11-27 |
Broad Inst Inc |
Novel Crispr Enzymes and Systems
|
CA3026112A1
(en)
|
2016-04-19 |
2017-10-26 |
The Broad Institute, Inc. |
Cpf1 complexes with reduced indel activity
|
CA3028074A1
(en)
|
2016-06-16 |
2018-12-20 |
Oslo Universitetssykehus Hf |
Improved gene editing
|
US11788083B2
(en)
|
2016-06-17 |
2023-10-17 |
The Broad Institute, Inc. |
Type VI CRISPR orthologs and systems
|
US20210222164A1
(en)
|
2016-06-29 |
2021-07-22 |
The Broad Institute, Inc. |
Crispr-cas systems having destabilization domain
|
KR20190039702A
(ko)
|
2016-07-05 |
2019-04-15 |
더 존스 홉킨스 유니버시티 |
H1 프로모터를 이용한 crispr 가이드 rna의 개선을 포함하는 조성물 및 방법
|
US11141463B2
(en)
|
2016-07-11 |
2021-10-12 |
The National Institute for Biotechnology in the Negev Ltd. |
Fusion proteins with extended serum half life
|
AU2017296352A1
(en)
|
2016-07-11 |
2019-02-21 |
Opko Biologics Ltd. |
Long-acting coagulation factor VII and methods of producing same
|
US11603533B2
(en)
|
2016-07-12 |
2023-03-14 |
Washington University |
Incorporation of internal polya-encoded poly-lysine sequence tags and their variations for the tunable control of protein synthesis in bacterial and eukaryotic cells
|
EP3484517A4
(de)
|
2016-07-18 |
2020-04-15 |
Ramot at Tel-Aviv University Ltd. |
Modulare plattform für gezielte therapeutika
|
SG11201900907YA
(en)
|
2016-08-03 |
2019-02-27 |
Harvard College |
Adenosine nucleobase editors and uses thereof
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
US11352647B2
(en)
|
2016-08-17 |
2022-06-07 |
The Broad Institute, Inc. |
Crispr enzymes and systems
|
US20200283743A1
(en)
|
2016-08-17 |
2020-09-10 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
JP2020501506A
(ja)
|
2016-09-07 |
2020-01-23 |
イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー. |
抗NKp46抗体およびその治療的使用
|
EP3515559A4
(de)
|
2016-09-20 |
2020-07-15 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzungen und verfahren zur identifizierung, beurteilung, prävention und behandlung von aml mit usp10-biomarkern und modulatoren
|
EP3519049A4
(de)
|
2016-09-30 |
2020-05-27 |
Janssen Biotech, Inc. |
Sicheres und effizientes verfahren zur behandlung von psoriasis mit anti-il23-spezifischem antikörper
|
EP3519824A1
(de)
|
2016-10-03 |
2019-08-07 |
Abbott Laboratories |
Verbesserte verfahren zur beurteilung des uch-l1-status in patientenproben
|
GB2573062A
(en)
|
2016-10-14 |
2019-10-23 |
Harvard College |
AAV delivery of nucleobase editors
|
SG10201913505WA
(en)
|
2016-10-17 |
2020-02-27 |
Univ Nanyang Tech |
Truncated crispr-cas proteins for dna targeting
|
MX2019005661A
(es)
|
2016-11-16 |
2019-10-07 |
Janssen Biotech Inc |
Método para tratar la psoriasis con el anticuerpo específico anti-il23.
|
WO2018096547A1
(en)
|
2016-11-28 |
2018-05-31 |
Yeda Research And Development Co. Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
EP3565834A1
(de)
|
2017-01-04 |
2019-11-13 |
The Research Institute at Nationwide Children's Hospital |
Antikörperfragmente zur behandlung von biofilmbedingten erkrankungen
|
WO2018129078A1
(en)
|
2017-01-04 |
2018-07-12 |
Research Institute At Nationwide Children's Hospital |
Dnabii vaccines and antibodies with enhanced activity
|
HRP20230937T1
(hr)
|
2017-01-05 |
2023-11-24 |
Kahr Medical Ltd. |
Pd1-41bbl fuzijski protein i metode korištenja istog
|
ES2916217T3
(es)
|
2017-01-05 |
2022-06-29 |
Kahr Medical Ltd |
Una proteína de fusión SIRP1 ALPHA-41BBL y métodos de uso de la misma
|
CA3051484A1
(en)
|
2017-01-27 |
2018-08-02 |
Memorial Sloan Kettering Cancer Center |
Bispecific her2 and cd3 binding molecules
|
EP3573658A4
(de)
|
2017-01-30 |
2021-07-21 |
Janssen Biotech, Inc. |
Anti-tnf-antikörper, zusammensetzungen und verfahren zur behandlung von aktiver psoriatischer arthritis
|
WO2018147915A1
(en)
|
2017-02-07 |
2018-08-16 |
Janssen Biotech, Inc. |
Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis
|
EP3592853A1
(de)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Unterdrückung von schmerzen durch geneditierung
|
WO2018165629A1
(en)
|
2017-03-10 |
2018-09-13 |
President And Fellows Of Harvard College |
Cytosine to guanine base editor
|
US11739308B2
(en)
|
2017-03-15 |
2023-08-29 |
The Broad Institute, Inc. |
Cas13b orthologues CRISPR enzymes and systems
|
US11746136B2
(en)
|
2017-03-15 |
2023-09-05 |
Research Institute At Nationwide Children's Hospital |
Composition and methods for disruption of bacterial biofilms without accompanying inflammation
|
CA3057192A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
US11016092B2
(en)
|
2017-03-23 |
2021-05-25 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1
|
KR20200006054A
(ko)
|
2017-04-12 |
2020-01-17 |
더 브로드 인스티튜트, 인코퍼레이티드 |
신규 타입 vi crispr 오르소로그 및 시스템
|
BR112019021612A2
(pt)
|
2017-04-15 |
2020-05-12 |
Abbott Laboratories |
Métodos para auxiliar o diagnóstico hiperagudo e determinação de traumatismo crânioencefálico em um indivíduo humano com o uso de biomarcadores precoces
|
EP3635407A1
(de)
|
2017-04-28 |
2020-04-15 |
Abbott Laboratories |
Verfahren zur unterstützung der hyperakuten diagnose und bestimmung von traumatischer hirnverletzung unter verwendung von frühbiomarkern auf mindestens zwei proben aus dem gleichen menschlichen patienten
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
SG11201911256UA
(en)
|
2017-05-08 |
2020-01-30 |
Orgenesis Ltd |
Transdifferentiated cell populations and methods of use thereof
|
US20210278416A1
(en)
|
2017-05-09 |
2021-09-09 |
The Broad Institute, Inc. |
Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
CN110651190A
(zh)
|
2017-05-25 |
2020-01-03 |
雅培实验室 |
用早期生物标记物帮助确定是否对已遭受或可能已遭受头部损伤的人受试者执行成像的方法
|
US11129564B2
(en)
|
2017-05-30 |
2021-09-28 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I
|
EP3634496A4
(de)
|
2017-06-06 |
2021-09-08 |
Dana-Farber Cancer Institute, Inc. |
Verfahren zur sensibilisierung von krebszellen gegen t-zell-vermittelte abtötung mittels modulierung von molekularen signalwegen
|
WO2019005884A1
(en)
|
2017-06-26 |
2019-01-03 |
The Broad Institute, Inc. |
CRISPR / CAS-ADENINE DEAMINASE COMPOSITIONS, SYSTEMS AND METHODS FOR TARGETED NUCLEIC ACID EDITION
|
US11169159B2
(en)
|
2017-07-03 |
2021-11-09 |
Abbott Laboratories |
Methods for measuring ubiquitin carboxy-terminal hydrolase L1 levels in blood
|
JP2020534795A
(ja)
|
2017-07-28 |
2020-12-03 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ファージによって支援される連続的進化(pace)を用いて塩基編集因子を進化させるための方法および組成物
|
US11319532B2
(en)
|
2017-08-30 |
2022-05-03 |
President And Fellows Of Harvard College |
High efficiency base editors comprising Gam
|
CN111511388A
(zh)
|
2017-09-21 |
2020-08-07 |
博德研究所 |
用于靶向核酸编辑的系统、方法和组合物
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
US11795443B2
(en)
|
2017-10-16 |
2023-10-24 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
US11547614B2
(en)
|
2017-10-31 |
2023-01-10 |
The Broad Institute, Inc. |
Methods and compositions for studying cell evolution
|
EP3706795A4
(de)
|
2017-11-09 |
2021-10-13 |
Pinteon Therapeutics Inc. |
Verfahren und zusammensetzungen zur erzeugung und verwendung von humanisierten konformationsspezifischen phosphorylierten tau-antikörpern
|
WO2019094983A1
(en)
|
2017-11-13 |
2019-05-16 |
The Broad Institute, Inc. |
Methods and compositions for treating cancer by targeting the clec2d-klrb1 pathway
|
US11016105B2
(en)
|
2017-12-09 |
2021-05-25 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1
|
CN111094983A
(zh)
|
2017-12-09 |
2020-05-01 |
雅培实验室 |
使用胶质细胞原纤维酸性蛋白(gfap)和/或泛素羧基末端水解酶l1(uch-l1)帮助诊断和评价已遭受骨科损伤并已遭受或可能已遭受头部损伤诸如轻度创伤性脑损伤(tbi)的患者的方法
|
JP7437303B2
(ja)
|
2017-12-29 |
2024-02-22 |
アボット・ラボラトリーズ |
外傷性脳損傷を診断及び査定するための、新規のバイオマーカー及び方法
|
WO2019150309A1
(en)
|
2018-02-02 |
2019-08-08 |
Hammack Scott |
Modulators of gpr68 and uses thereof for treating and preventing diseases
|
EP3762015A4
(de)
|
2018-03-05 |
2022-04-27 |
Janssen Biotech, Inc. |
Verfahren zur behandlung von morbus crohn mit anti-il23-spezifischem antikörper
|
JP2021517564A
(ja)
|
2018-03-12 |
2021-07-26 |
メモリアル スローン ケタリング キャンサー センター |
二重特異性結合因子およびその使用
|
KR20200139219A
(ko)
|
2018-04-02 |
2020-12-11 |
브리스톨-마이어스 스큅 컴퍼니 |
항-trem-1 항체 및 이의 용도
|
US10968257B2
(en)
|
2018-04-03 |
2021-04-06 |
The Broad Institute, Inc. |
Target recognition motifs and uses thereof
|
WO2019209807A1
(en)
|
2018-04-23 |
2019-10-31 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for modulating endoplasmic reticulum-associated degradation
|
WO2019211842A1
(en)
|
2018-04-30 |
2019-11-07 |
Opko Biologics Ltd. |
Long-acting human growth hormone-antagonists and methods of producing the same
|
US20210239700A1
(en)
|
2018-05-04 |
2021-08-05 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
WO2019215701A1
(en)
|
2018-05-11 |
2019-11-14 |
Janssen Biotech, Inc. |
Methods of treating depression using il-23 antibodies
|
US20210198330A1
(en)
|
2018-05-23 |
2021-07-01 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
TW202016144A
(zh)
|
2018-06-21 |
2020-05-01 |
日商第一三共股份有限公司 |
包括cd3抗原結合片段之組成物及其用途
|
WO2020003311A1
(en)
|
2018-06-25 |
2020-01-02 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
EP3814385A4
(de)
|
2018-07-11 |
2022-04-06 |
KAHR Medical Ltd. |
Sirpalpha-4-1bbl-fusionsproteinvariante und ihre verwendung
|
US20210278406A1
(en)
|
2018-07-13 |
2021-09-09 |
Varct Diagnostic Aps |
Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa
|
JP2021530697A
(ja)
|
2018-07-18 |
2021-11-11 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il23特異的抗体で治療した後の持続応答予測因子
|
EP3833761A1
(de)
|
2018-08-07 |
2021-06-16 |
The Broad Institute, Inc. |
Neuartige cas12b-enzyme und systeme
|
US20210317429A1
(en)
|
2018-08-20 |
2021-10-14 |
The Broad Institute, Inc. |
Methods and compositions for optochemical control of crispr-cas9
|
WO2020041360A1
(en)
|
2018-08-21 |
2020-02-27 |
Quidel Corporation |
Dbpa antibodies and uses thereof
|
PL3883606T3
(pl)
|
2018-09-24 |
2023-11-27 |
Janssen Biotech, Inc. |
Bezpieczny i skuteczny sposób leczenia wrzodziejącego zapalenia jelita grubego przeciwciałami anty-il12/il23
|
US20210338783A1
(en)
|
2018-10-05 |
2021-11-04 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for enzymatic disruption of bacterial biofilms
|
EP3870695A1
(de)
|
2018-10-22 |
2021-09-01 |
University of Rochester |
Genomeditierung durch gerichtete nicht-homologe dna-insertion unter verwendung eines retroviralen integrase-cas9-fusionsproteins
|
WO2020092448A1
(en)
|
2018-10-29 |
2020-05-07 |
Spin Therapeutics, Llc |
Compositions and methods for alpha-1-antitrypsin disorders
|
US20220282275A1
(en)
|
2018-11-15 |
2022-09-08 |
The Broad Institute, Inc. |
G-to-t base editors and uses thereof
|
CN113395979A
(zh)
|
2018-11-20 |
2021-09-14 |
詹森生物科技公司 |
用抗il-23特异性抗体治疗银屑病的安全且有效的方法
|
WO2020128864A1
(en)
|
2018-12-18 |
2020-06-25 |
Janssen Biotech, Inc. |
Safe and effective method of treating lupus with anti-il12/il23 antibody
|
EP3911741A1
(de)
|
2019-01-14 |
2021-11-24 |
University of Rochester |
Gezielte nukleäre rna-spaltung und polyadenylierung mit crispr-cas
|
WO2020148651A1
(en)
|
2019-01-15 |
2020-07-23 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions and methods for the treatment of juvenile idiopathic arthritis
|
CN113330031A
(zh)
|
2019-01-23 |
2021-08-31 |
詹森生物科技公司 |
用于在治疗银屑病关节炎的方法中使用的抗tnf抗体组合物
|
US20220170013A1
(en)
|
2019-03-06 |
2022-06-02 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenosine methylation
|
WO2020181202A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to t:a base editing through adenine deamination and oxidation
|
WO2020181195A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenine excision
|
WO2020181180A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to c:g base editors and uses thereof
|
WO2020181178A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through thymine alkylation
|
JP2022525179A
(ja)
|
2019-03-14 |
2022-05-11 |
ヤンセン バイオテツク,インコーポレーテツド |
抗tnf抗体組成物を産生するための産生方法
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
CN113840837A
(zh)
|
2019-03-14 |
2021-12-24 |
詹森生物科技公司 |
用于产生抗tnf抗体组合物的方法
|
US20220144934A1
(en)
|
2019-03-14 |
2022-05-12 |
Janssen Biotech, Inc. |
Methods for Producing Anti-TNF Antibody Compositions
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
JP2022525145A
(ja)
|
2019-03-14 |
2022-05-11 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il12/il23抗体組成物を生成するための製造方法
|
US20220177863A1
(en)
|
2019-03-18 |
2022-06-09 |
The Broad Institute, Inc. |
Type vii crispr proteins and systems
|
BR112021018441A2
(pt)
|
2019-03-18 |
2023-02-28 |
Janssen Biotech Inc |
Método para tratamento de psoríase em indivíduos pediátricos com anticorpo anti-il12/il23
|
WO2020191153A2
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
US20220307003A1
(en)
|
2019-04-17 |
2022-09-29 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
EP3962529A4
(de)
|
2019-04-30 |
2023-11-01 |
Dana-Farber Cancer Institute, Inc. |
Verfahren zur krebsbehandlung unter verwendung von kombinationen aus anti-cx3cr1 und immuncheckpoint-blockierungsreagenzien
|
EP3969026A1
(de)
|
2019-05-16 |
2022-03-23 |
Ceva Santé Animale |
Zusammensetzungen und verfahren zur erhöhung der reproduktionsleistung bei nichtmenschlichen säugetieren unter verwendung des rekombinanten luteinisierenden hormons
|
US20220220469A1
(en)
|
2019-05-20 |
2022-07-14 |
The Broad Institute, Inc. |
Non-class i multi-component nucleic acid targeting systems
|
AU2020279987A1
(en)
|
2019-05-23 |
2021-11-18 |
Janssen Biotech, Inc. |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
|
KR20220029593A
(ko)
|
2019-06-03 |
2022-03-08 |
얀센 바이오테크 인코포레이티드 |
건선성 관절염의 치료를 위한 항-tnf 항체 조성물, 및 방법
|
AU2020288404A1
(en)
|
2019-06-03 |
2022-02-03 |
Janssen Biotech, Inc. |
Anti-TNF antibodies, compositions, and methods for the treatment of active Ankylosing Spondylitis
|
WO2020261097A1
(en)
|
2019-06-26 |
2020-12-30 |
Glaxosmithkline Intellectual Property Development Limited |
Il1rap binding proteins
|
EP3997120A4
(de)
|
2019-07-08 |
2023-11-22 |
Research Institute at Nationwide Children's Hospital |
Antikörperzusammensetzungen zur unterbrechung von biofilmen
|
WO2021005604A1
(en)
|
2019-07-11 |
2021-01-14 |
Opko Biologics Ltd. |
Long-acting igf-1 or igf-1 variants and methods of producing same
|
AU2020311636A1
(en)
|
2019-07-11 |
2022-03-03 |
Kahr Medical Ltd. |
Heterodimers and methods of use thereof
|
WO2021016453A1
(en)
|
2019-07-23 |
2021-01-28 |
University Of Rochester |
Targeted rna cleavage with crispr-cas
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
WO2021030666A1
(en)
|
2019-08-15 |
2021-02-18 |
The Broad Institute, Inc. |
Base editing by transglycosylation
|
CN114729384A
(zh)
|
2019-09-12 |
2022-07-08 |
博德研究所 |
工程化腺相关病毒衣壳
|
US11266129B2
(en)
|
2019-11-05 |
2022-03-08 |
Versiti Blood Research Institute Foundation, Inc. |
Murine model of fetal/neonatal alloimmune thrombocytopenia
|
JP2023500896A
(ja)
|
2019-11-05 |
2023-01-11 |
ヴァーシティ ブラッド リサーチ インスティテュート ファウンデーション, インコーポレイテッド |
胎児/新生児同種抗体血小板減少症のマウスモデル
|
WO2021095031A2
(en)
|
2019-11-11 |
2021-05-20 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Insect control nanobodies and uses thereof
|
US20230086199A1
(en)
|
2019-11-26 |
2023-03-23 |
The Broad Institute, Inc. |
Systems and methods for evaluating cas9-independent off-target editing of nucleic acids
|
CN115298213A
(zh)
|
2019-12-19 |
2022-11-04 |
奎多公司 |
单克隆抗体融合
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
WO2021158921A2
(en)
|
2020-02-05 |
2021-08-12 |
The Broad Institute, Inc. |
Adenine base editors and uses thereof
|
WO2021195525A1
(en)
|
2020-03-27 |
2021-09-30 |
University Of Rochester |
Crispr-cas13 crrna arrays
|
JP2023519307A
(ja)
|
2020-03-27 |
2023-05-10 |
ユニバーシティ オブ ロチェスター |
Crispr-cas13によるウイルスrnaの標的化破壊
|
EP4136459A1
(de)
|
2020-04-13 |
2023-02-22 |
Abbott Laboratories |
Verfahren, komplexe und kits zum nachweis oder zur bestimmung einer menge eines ss-coronavirus-antikörpers in einer probe
|
KR20230019843A
(ko)
|
2020-05-08 |
2023-02-09 |
더 브로드 인스티튜트, 인코퍼레이티드 |
표적 이중 가닥 뉴클레오티드 서열의 두 가닥의 동시 편집을 위한 방법 및 조성물
|
JP2023534464A
(ja)
|
2020-07-15 |
2023-08-09 |
ユニバーシティ オブ ロチェスター |
dCas13-RNase融合タンパク質による標的RNAの切断
|
JP2023535695A
(ja)
|
2020-07-20 |
2023-08-21 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
コロナウイルス感染症の治療及び予防のための方法及び組成物
|
WO2022031804A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Laboratories |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
WO2022034374A2
(en)
|
2020-08-11 |
2022-02-17 |
University Of Oslo |
Improved gene editing
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
CA3198161A1
(en)
|
2020-12-01 |
2022-06-09 |
Beth MCQUISTON |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
EP4271998A1
(de)
|
2020-12-30 |
2023-11-08 |
Abbott Laboratories |
Verfahren zur bestimmung des sars-cov-2-antigens und anti-sars-cov-2-antikörpers in einer probe
|
TW202237135A
(zh)
|
2021-01-13 |
2022-10-01 |
紀念斯隆凱特琳癌症中心 |
抗體-吡咯并苯并二氮呯衍生物結合物
|
WO2022153195A1
(en)
|
2021-01-13 |
2022-07-21 |
Memorial Sloan Kettering Cancer Center |
Anti-dll3 antibody-drug conjugate
|
AU2022233792A1
(en)
|
2021-03-12 |
2023-10-26 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriatic arthritis with anti-il23 specific antibody
|
KR20230156764A
(ko)
|
2021-03-12 |
2023-11-14 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체에 의해 tnf 요법에 부적절한 반응을 보이는 건선성 관절염 환자를 치료하는 방법
|
CA3216146A1
(en)
|
2021-04-23 |
2022-10-27 |
Douglas Anderson |
Genome editing by directed non-homologous dna insertion using a retroviral integrase-cas fusion protein and methods of treatment
|
JP2024519858A
(ja)
|
2021-05-18 |
2024-05-21 |
アボット・ラボラトリーズ |
小児対象における脳損傷を査定する方法
|
WO2022243937A1
(en)
|
2021-05-20 |
2022-11-24 |
Janssen Biotech, Inc. |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
|
WO2022261183A2
(en)
|
2021-06-08 |
2022-12-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
|
WO2022261509A1
(en)
|
2021-06-11 |
2022-12-15 |
The Broad Institute, Inc. |
Improved cytosine to guanine base editors
|
EP4356129A1
(de)
|
2021-06-14 |
2024-04-24 |
Abbott Laboratories |
Verfahren zur diagnose oder unterstützung der diagnose von hirnverletzungen durch akustische energie, elektromagnetische energie, überdruckwelle und/oder explosionswind
|
IL309996A
(en)
|
2021-07-09 |
2024-03-01 |
Janssen Biotech Inc |
Production methods for the production of anti-TNF antibody compositions
|
KR20240034215A
(ko)
|
2021-07-09 |
2024-03-13 |
얀센 바이오테크 인코포레이티드 |
항-il12/il23 항체 조성물을 생산하기 위한 제조 방법
|
IL309997A
(en)
|
2021-07-09 |
2024-03-01 |
Janssen Biotech Inc |
Production methods for the production of anti-TNF antibody compositions
|
EP4373837A2
(de)
|
2021-07-20 |
2024-05-29 |
The Broad Institute, Inc. |
Manipulierte targeting-zusammensetzungen für endothelzellen der vaskulatur des zentralnervensystems und verfahren zur verwendung davon
|
WO2023028186A1
(en)
|
2021-08-27 |
2023-03-02 |
Abbott Laboratories |
Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
|
WO2023034777A1
(en)
|
2021-08-31 |
2023-03-09 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
AU2022354059A1
(en)
|
2021-09-30 |
2024-03-28 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
CA3236779A1
(en)
|
2021-10-29 |
2023-05-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
WO2023084488A1
(en)
|
2021-11-15 |
2023-05-19 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
US20230159633A1
(en)
|
2021-11-23 |
2023-05-25 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|
WO2023097119A2
(en)
|
2021-11-29 |
2023-06-01 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to modulate riok2
|
WO2023114978A1
(en)
|
2021-12-17 |
2023-06-22 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
US20230213536A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
US20230312703A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of Treating Psoriasis with IL-23 Specific Antibody
|
WO2023196802A1
(en)
|
2022-04-04 |
2023-10-12 |
The Broad Institute, Inc. |
Cas9 variants having non-canonical pam specificities and uses thereof
|
WO2023223265A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for evaluating and treating psoriatic arthritis with il23 antibody
|
WO2023240137A1
(en)
|
2022-06-08 |
2023-12-14 |
The Board Institute, Inc. |
Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
|
WO2024006876A1
(en)
|
2022-06-29 |
2024-01-04 |
Abbott Laboratories |
Magnetic point-of-care systems and assays for determining gfap in biological samples
|
WO2024016003A2
(en)
|
2022-07-14 |
2024-01-18 |
The Broad Institute, Inc. |
Aav capsids that enable cns-wide gene delivery through interactions with the transferrin receptor
|
WO2024040083A1
(en)
|
2022-08-16 |
2024-02-22 |
The Broad Institute, Inc. |
Evolved cytosine deaminases and methods of editing dna using same
|
WO2024047587A1
(en)
|
2022-08-31 |
2024-03-07 |
Regel Therapeutics, Inc. |
Cas-phi compositions and methods of use
|
WO2024059692A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|
WO2024081245A1
(en)
|
2022-10-10 |
2024-04-18 |
Therapeutics By Design, LLC |
Tissue differentiation factor related polypeptides (tdfrps) for the treatment of myocardial injury
|